Doença de Alzheimer (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Doença de Alzheimer" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

235nih.gov

4^th place

8^th place

212doi.org

2^nd place

4^th place

17web.archive.org

1^st place

4worldcat.org

5^th place

4clinicaltrials.gov

5,225^th place

low place

3nice.org.uk

3,258^th place

5,177^th place

2who.int

195^th place

150^th place

2fda.gov

447^th place

869^th place

2alz.org

low place

2ucl.ac.uk

1,306^th place

1,471^st place

1consumerreports.org

4,720^th place

7,779^th place

1metapress.com

8,671^st place

7,120^th place

1technology.org

low place

1europa.eu

68^th place

56^th place

1arquivo.pt

1,668^th place

738^th place

1diagnosticimaging.com

low place

1dgs.pt

low place

1scielo.br

1,606^th place

44^th place

1ama-assn.org

3,257^th place

4,674^th place

1neurology.org

9,919^th place

low place

1upol.cz

low place

1frx.com

low place

1physorg.com

6,156^th place

4,645^th place

1gerontologyjournals.org

low place

1books.google.com

3^rd place

6^th place

1wiley.com

222^nd place

196^th place

1bvsalud.org

9,583^rd place

914^th place

1census.gov

45^th place

41^st place

1bepress.com

7,958^th place

low place

1un.org

97^th place

116^th place

1metlife.com

low place

1ufrj.br

6,631^st place

201^st place

1jbc.org

4,455^th place

5,292^nd place

1adisonline.com

low place

1medivation.com

low place

1abril.com.br

508^th place

9^th place

1cnn.com

28^th place

50^th place

1mit.edu

415^th place

453^rd place

1nytimes.com

7^th place

14^th place

1techexplorist.com

low place

409^th place

1patientslikeme.com

low place

1curetogether.com

low place

1kurzweilai.net

low place

1wellcome.ac.uk

low place

1obviousmag.org

low place

3,305^th place

1discovermagazine.com

3,042^nd place

2,711^th place

1medcitynews.com

low place

1brightfocus.org

low place

abril.com.br

info.abril.com.br

«Cópia arquivada». Consultado em 24 de julho de 2015. Arquivado do original em 26 de julho de 2015

adisonline.com

Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W (2010). «Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence». Drugs. 70 (5): 513–528. PMID 20329802. doi:10.2165/11533070-000000000-00000. Consultado em 22 de novembro de 2014. Arquivado do original em 17 de setembro de 2011

alz.org

«What We Know Today About Alzheimer's Disease». Alzheimer's Association. Consultado em 1 de outubro de 2011. While scientists know Alzheimer's disease involves progressive brain cell failure, the reason cells fail isn't clear.
«Anxiety and Agitation». Alzheimer's Association. 2006. Consultado em 25 de setembro de 2006. Cópia arquivada em 25 de setembro de 2006

ama-assn.org

archpsyc.ama-assn.org

Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, Rosenberg I, Mwamburi DM, Qiu WQ (2008). «Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?». Archives of General Psychiatry. 65 (5): 542–550. PMC 3042807. PMID 18458206. doi:10.1001/archpsyc.65.5.542

arquivo.pt

Moan R (20 de julho de 2009). «MRI Software Accurately IDs Preclinical Alzheimer's Disease». Diagnostic Imaging. Consultado em 17 de novembro de 2014. Arquivado do original em 16 de maio de 2016

bepress.com

works.bepress.com

Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007). «Forecasting the global burden of Alzheimer's disease». Alzheimer's & Dementia. 3 (3): 186–91. PMID 19595937. doi:10.1016/j.jalz.2007.04.381

books.google.com

Dudek, Susan G. (2007). Lippincott Williams & Wilkins, ed. Nutrition Essentials for Nursing Practice. Hagerstown, Maryland: [s.n.] 360 páginas. ISBN 0-7817-6651-6

brightfocus.org

«First-Ever Citizen Science Project for Alzheimer's Research Gets 10,000th Volunteer». BrightFocus Foundation (em inglês). 7 de maio de 2018

bvsalud.org

pepsic.bvsalud.org

Raquel Lemos; Cristina Martins; Mário R. Simões; Isabel Santana (2012). «Estudo de adaptação do Teste de Recordação Selectiva Livre e Guiada para a população portuguesa». Aval. psicol. 11 (1)

census.gov

«Profiles of General Demographic Characteristics, 2000 Census of Population and Housing, United States» (PDF). U.S. Census Bureau. 2001. Consultado em 10 de outubro de 2014. Cópia arquivada (PDF) em 19 de agosto de 2008

clinicaltrials.gov

«Clinical Trials. Found 1012 studies with search of: alzheimer». US National Institutes of Health. Consultado em 10 de Janeiro de 2011
«Bapineuzumab in Patients with Mild to Moderate Alzheimer's Disease/ Apo_e4 Non-carriers». US National Institutes of Health. 29 de fevereiro de 2008. Consultado em 23 de março de 2008. Cópia arquivada em 22 de março de 2008
«Safety, Tolerability and Efficacy Study to Evaluate Subjects with Mild Cognitive Impairment». US National Institutes of Health. 11 de março de 2008. Consultado em 23 de março de 2008
«Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients with Early Alzheimer's Disease». US National Institutes of Health. 13 de janeiro de 2008. Consultado em 23 de março de 2008

cnn.com

Could the DNA-editing CRISPR revolutionize medicine? por Carina Storrs publicado na CNN em 12 de agosto de 2015

consumerreports.org

Consumer Reports; Drug Effectiveness Review Project (Maio de 2012). «Evaluating Prescription Drugs Used to Treat: Alzheimer's Disease Comparing Effectiveness, Safety, and Price» (PDF). Consumer Reports: 2

curetogether.com

Cure Together

dgs.pt

Abordagem Terapêutica das Alterações Cognitivas. Norma nº 053/2011 de 27/12/2011. [S.l.]: Direcção-Geral da Saúde. 2011. pp. 3–4

diagnosticimaging.com

Moan R (20 de julho de 2009). «MRI Software Accurately IDs Preclinical Alzheimer's Disease». Diagnostic Imaging. Consultado em 17 de novembro de 2014. Arquivado do original em 16 de maio de 2016

discovermagazine.com

blogs.discovermagazine.com

The Science Behind WeCureALZ: A Participatory Research Project Tackling Alzheimer’s Disease (2016)

doi.org

dx.doi.org

Burns A, Iliffe S (fevereiro de 2009). «Alzheimer's disease». BMJ. 338: b158. ISSN 0959-8138. PMID 19196745. doi:10.1136/bmj.b158. (pede subscrição (ajuda))
Mendez MF (novembro de 2012). «Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD». Archives of Medical Research. 43 (8): 677–85. PMC 3532551. PMID 23178565. doi:10.1016/j.arcmed.2012.11.009
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (março de 2011). «Alzheimer's disease». Lancet. 377 (9770): 1019–31. PMID 21371747. doi:10.1016/S0140-6736(10)61349-9
Querfurth HW, LaFerla FM (janeiro de 2010). «Alzheimer's disease». The New England Journal of Medicine. 362 (4): 329–44. PMID 20107219. doi:10.1056/NEJMra0909142
«Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1545–1602. Outubro de 2016. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
«Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1459–1544. Outubro de 2016. PMC 5388903. PMID 27733281. doi:10.1016/S0140-6736(16)31012-1
Todd S, Barr S, Roberts M, Passmore AP (novembro de 2013). «Survival in dementia and predictors of mortality: a review». International Journal of Geriatric Psychiatry. 28 (11): 1109–24. PMID 23526458. doi:10.1002/gps.3946
Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward. Current Alzheimer research. 2017;14(4):426-440. doi:10.2174/1567205013666160930112125. PMID 27697063.
Systematic Review of Information and Support Interventions for Caregivers of People with Dementia. BMC Geriatrics. 2007;7:18. doi:10.1186/1471-2318-7-18. PMID 17662119.
Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (abril de 2015). «Exercise programs for people with dementia». The Cochrane Database of Systematic Reviews (4): CD006489. PMID 25874613. doi:10.1002/14651858.CD006489.pub4
Evolution in the Conceptualization of Dementia and Alzheimer's Disease: Greco-Roman Period to the 1960s. Neurobiology of Aging. 1998;19(3):173–89. doi:10.1016/S0197-4580(98)00052-9. PMID 9661992.
Impact économique de la démence (English: The Economical Impact of Dementia). Presse Médicale. 2005;34(1):35–41. French. doi:10.1016/s0755-4982(05)83882-5. PMID 15685097.
Economic Considerations in Alzheimer's Disease. Pharmacotherapy. 1998;18(2 Pt 2):68–73; discussion 79–82. doi:10.1002/j.1875-9114.1998.tb03880.x. PMID 9543467.
Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B (2007). «Recommendations for the Diagnosis and Management of Alzheimer's Disease and Other Disorders Associated with Dementia: EFNS Guideline». European Journal of Neurology. 14 (1): e1–26. PMID 17222085. doi:10.1111/j.1468-1331.2006.01605.x
Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ (2004). «Multiple Cognitive Deficits During the Transition to Alzheimer's Disease». Journal of Internal Medicine. 256 (3): 195–204. PMID 15324363. doi:10.1111/j.1365-2796.2004.01386.x
Nygård L (2003). «Instrumental Activities of Daily Living: A Stepping-stone Towards Alzheimer's Disease Diagnosis in Subjects with Mild Cognitive Impairment?». Acta Neurologica Scandinavica. Suppl (179): 42–6. PMID 12603250. doi:10.1034/j.1600-0404.107.s179.8.x
Arnáiz E, Almkvist O (2003). «Neuropsychological Features of Mild Cognitive Impairment and Preclinical Alzheimer's Disease». Acta Neurologica Scandinavica. 179: 34–41. PMID 12603249. doi:10.1034/j.1600-0404.107.s179.7.x
Landes AM, Sperry SD, Strauss ME, Geldmacher DS (2001). «Apathy in Alzheimer's Disease». Journal of the American Geriatrics Society. 49 (12): 1700–7. PMID 11844006. doi:10.1046/j.1532-5415.2001.49282.x
Petersen RC (2007). «The Current Status of Mild Cognitive Impairment—What Do We Tell Our Patients?». Nature Clinical Practice. Neurology. 3 (2): 60–1. PMID 17279076. doi:10.1038/ncpneuro0402
Förstl H, Kurz A (1999). «Clinical Features of Alzheimer's Disease». European Archives of Psychiatry and Clinical Neuroscience. 249 (6): 288–290. PMID 10653284. doi:10.1007/s004060050101
Carlesimo GA, Oscar-Berman M (1992). «Memory Deficits in Alzheimer's Patients: A Comprehensive Review». Neuropsychology Review. 3 (2): 119–69. PMID 1300219. doi:10.1007/BF01108841
Jelicic M, Bonebakker AE, Bonke B (1995). «Implicit Memory Performance of Patients with Alzheimer's Disease: A Brief Review». International Psychogeriatrics. 7 (3): 385–392. PMID 8821346. doi:10.1017/S1041610295002134
Taler V, Phillips NA (Julho de 2008). «Language Performance in Alzheimer's Disease and Mild Cognitive Impairment: a comparative review». Journal of Clinical and Experimental Neuropsychology. 30 (5): 501–56. PMID 18569251. doi:10.1080/13803390701550128
Wilson RS, Barral S, Lee JH, Leurgans SE, Foroud TM, Sweet RA, Graff-Radford N, Bird TD, Mayeux R, Bennett DA (2011). «Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study.». J Alzheimers Dis. 23 (2): 249-55. PMID 20930268. doi:10.3233/JAD-2010-101515
Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL (2006). «Role of genes and environments for explaining Alzheimer disease». Arch Gen Psychiatry. 63 (2): 168-74. PMID 16461860. doi:10.1001/archpsyc.63.2.168
Blennow K, de Leon MJ, Zetterberg H (2006). «Alzheimer's Disease». Lancet. 368 (9533): 387–403. PMID 16876668. doi:10.1016/S0140-6736(06)69113-7
Waring SC, Rosenberg RN (2008). «Genome-wide association studies in Alzheimer disease». Archives of Neurology. 65 (3): 329–34. PMID 18332245. doi:10.1001/archneur.65.3.329
Selkoe DJ (1999). «Translating cell biology into therapeutic advances in Alzheimer's disease». Nature. 399 (6738 Suppl): A23–31. PMID 10392577. doi:10.1038/19866
Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS (1996). «Familial Alzheimer's disease-linked presenilin 1 variants elevate βA1-42/1-40 ratio in vitro and in vivo». Neuron. 17 (5): 1005–13. PMID 8938131. doi:10.1016/S0896-6273(00)80230-5
Shioi J, Georgakopoulos A, Mehta P, Kouchi Z, Litterst CM, Baki L, Robakis NK (2007). «FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta». Journal of Neurochemistry. 101 (3): 674–81. PMID 17254019. doi:10.1111/j.1471-4159.2006.04391.x
Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K (2 de agosto de 2012). «A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.». Nature. 488 (7409): 96–9. PMID 22801501. doi:10.1038/nature11283
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993). «Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease». Proceedings of the National Academy of Sciences of the United States of America. 90 (5): 1977–81. PMC 46003. PMID 8446617. doi:10.1073/pnas.90.5.1977
Mahley RW, Weisgraber KH, Huang Y (2006). «Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease». Proceedings of the National Academy of Sciences of the United States of America. 103 (15): 5644–51. PMC 1414631. PMID 16567625. doi:10.1073/pnas.0600549103
Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H (2006). «Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba». Neurology. 66 (2): 223–227. PMC 2860622. PMID 16434658. doi:10.1212/01.wnl.0000194507.39504.17
Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, Smith-Gamble V, Lane KA, Gao S, Hall KS, Hendrie HC, Murrell JR (2006). «APOE ε4 is not associated with Alzheimer's disease in elderly Nigerians». Annals of Neurology. 59 (1): 182–185. PMC 2855121. PMID 16278853. doi:10.1002/ana.20694
Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K (2012). «Variant of TREM2 associated with the risk of Alzheimer's disease». The New England Journal of Medicine (Original article). 368 (2): 107–16. PMC 3677583. PMID 23150908. doi:10.1056/NEJMoa1211103
Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J (2012). «TREM2 variants in Alzheimer's disease». The New England Journal of Medicine (Original article). 368 (2): 117–27. PMC 3631573. PMID 23150934. doi:10.1056/NEJMoa1211851
Lambert, JC (2013). «Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.». Nature Genetics. 45 (12): 1452–8. PMC 3896259. PMID 24162737. doi:10.1038/ng.2802
Francis PT, Palmer AM, Snape M, Wilcock GK (1999). «The Cholinergic Hypothesis of Alzheimer's Disease: a Review of Progress». Journal of Neurology, Neurosurgery, and Psychiatry. 66 (2): 137–47. PMC 1736202. PMID 10071091. doi:10.1136/jnnp.66.2.137
Shen ZX (2004). «Brain Cholinesterases: II. The Molecular and Cellular Basis of Alzheimer's Disease». Medical Hypotheses. 63 (2): 308–21. PMID 15236795. doi:10.1016/j.mehy.2004.02.031
Hardy J, Allsop D (1991). «Amyloid Deposition as the Central Event in the Aetiology of Alzheimer's Disease». Trends in Pharmacological Sciences. 12 (10): 383–88. PMID 1763432. doi:10.1016/0165-6147(91)90609-V
Mudher A, Lovestone S (2002). «Alzheimer's disease-do tauists and baptists finally shake hands?». Trends in Neurosciences. 25 (1): 22–26. PMID 11801334. doi:10.1016/S0166-2236(00)02031-2
Nistor M, Don M, Parekh M, Sarsoza F, Goodus M, Lopez GE, Kawas C, Leverenz J, Doran E, Lott IT, Hill M, Head E (2007). «Alpha- and Beta-secretase Activity as a Function of Age and Beta-amyloid in Down Syndrome and Normal Brain». Neurobiology of Aging. 28 (10): 1493–1506. PMC 3375834. PMID 16904243. doi:10.1016/j.neurobiolaging.2006.06.023
Lott IT, Head E (2005). «Alzheimer Disease and Down Syndrome: Factors in Pathogenesis». Neurobiology of Aging. 26 (3): 383–89. PMID 15639317. doi:10.1016/j.neurobiolaging.2004.08.005
Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K (1995). «Apolipoprotein E, Dementia, and Cortical Deposition of Beta-amyloid Protein». The New England Journal of Medicine. 333 (19): 1242–47. PMID 7566000. doi:10.1056/NEJM199511093331902
Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F (1995). «Alzheimer-type Neuropathology in Transgenic Mice Overexpressing V717F Beta-amyloid Precursor Protein». Nature. 373 (6514): 523–27. PMID 7845465. doi:10.1038/373523a0
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996). «Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice». Science. 274 (5284): 99–102. PMID 8810256. doi:10.1126/science.274.5284.99
Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C, Strazielle C (2002). «Spatial Learning, Exploration, Anxiety, and Motor Coordination in Female APP23 Transgenic Mice with the Swedish Mutation». Brain Research. 956 (1): 36–44. PMID 12426044. doi:10.1016/S0006-8993(02)03476-5
Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008). «Long-term Effects of Abeta42 Immunisation in Alzheimer's Disease: Follow-up of a Randomised, Placebo-controlled Phase I Trial». Lancet. 372 (9634): 216–23. PMID 18640458. doi:10.1016/S0140-6736(08)61075-2
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007). «Aß Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease». The Journal of Neuroscience. 27 (4): 796–807. PMID 17251419. doi:10.1523/JNEUROSCI.3501-06.2007
Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009). «Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers». Nature. 457 (7233): 1128–32. PMC 2748841. PMID 19242475. doi:10.1038/nature07761
Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M (19 de fevereiro de 2009). «APP Binds DR6 to Cause Axon Pruning and Neuron Death via Distinct Caspases». Nature. 457 (7232): 981–989. ISSN 0028-0836. PMC 2677572. PMID 19225519. doi:10.1038/nature07767
Goedert M, Spillantini MG, Crowther RA (1991). «Tau Proteins and Neurofibrillary Degeneration». Brain Pathology (Zurich, Switzerland). 1 (4): 279–86. PMID 1669718. doi:10.1111/j.1750-3639.1991.tb00671.x
Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005). «Tau Pathology in Alzheimer Disease and Other Tauopathies». Biochimica Et Biophysica Acta. 1739 (2–3): 198–210. PMID 15615638. doi:10.1016/j.bbadis.2004.09.008
Chun W, Johnson GV (2007). «The Role of Tau Phosphorylation and Cleavage in Neuronal Cell Death». Frontiers in Bioscience: A Journal and Virtual Library. 12: 733–56. PMID 17127334. doi:10.2741/2097
Xu H, Finkelstein DI, Adlard PA (12 de junho de 2014). «Interactions of metals and Apolipoprotein E in Alzheimer's disease». Front Aging Neurosci. 6. 121 páginas. PMC 4054654. PMID 24971061. doi:10.3389/fnagi.2014.00121. Although we still do not know if the metal ion dyshomeostasis present in AD is a cause or consequence of the disease, there is a growing body of evidence showing a direct correlation between metal ions and key AD-related key proteins.
Santibáñez M, Bolumar F, García AM (2007). «Occupational Risk Factors in Alzheimer's Disease: A Review Assessing the Quality of Published Epidemiological Studies». Occupational and Environmental Medicine. 64 (11): 723–732. PMC 2078415. PMID 17525096. doi:10.1136/oem.2006.028209
Rondeau V (2002). «A Review of Epidemiologic Studies on Aluminum and Silica in Relation to Alzheimer's Disease and Associated Disorders». Reviews on Environmental Health. 17 (2): 107–21. PMID 12222737. doi:10.1515/REVEH.2002.17.2.107
Brewer GJ (Março de 2012). «Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease». BioFactors (Oxford, England). 38 (2): 107–113. PMID 22438177. doi:10.1002/biof.1005
Bartzokis G (Agosto de 2011). «Alzheimer's Disease as Homeostatic Responses to Age-related Myelin Breakdown». Neurobiology of Aging. 32 (8): 1341–71. PMC 3128664. PMID 19775776. doi:10.1016/j.neurobiolaging.2009.08.007
Bartzokis G, Lu PH, Mintz J (Abril de 2007). «Human Brain Myelination and Beta-amyloid Deposition in Alzheimer's Disease». Alzheimer's & Dementia. 3 (2): 122–5. PMC 2442864. PMID 18596894. doi:10.1016/j.jalz.2007.01.019
Su B, Wang X, Nunomura A, Moreira PI, Lee HG, Perry G, Smith MA, Zhu X (Dezembro de 2008). «Oxidative Stress Signaling in Alzheimer's Disease». Current Alzheimer Research. 5 (6): 525–32. PMC 2780015. PMID 19075578. doi:10.2174/156720508786898451
Kastenholz B, Garfin DE, Horst J, Nagel KA (2009). «Plant Metal Chaperones: A Novel Perspective in Dementia Therapy». Amyloid: The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis. 16 (2): 81–3. PMID 20536399. doi:10.1080/13506120902879392
Pohanka M (2013). «Alzheimer´s Disease and Oxidative Stress: A Review». Current Medicinal Chemistry (Review). 21 (3): 356–64. PMID 24059239. doi:10.2174/09298673113206660258
Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, Jardanhazi-Kurutz D, Walter J, Kirchhoff F, Hanisch UK, Kummer MP. (2010). «Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine» (PDF). Proceedings of the National Academy of Sciences of the United States of America. 107: 6058–6063. PMID 20231476. doi:10.1073/pnas.0909586107
Cataldo JK, Prochaska JJ, Glantz SA (2010). «Cigarette smoking is a risk factor for Alzheimer's disease: An analysis controlling for tobacco industry affiliation». Journal of Alzheimer's Disease. 19 (2): 465–80. PMC 2906761. PMID 20110594. doi:10.3233/JAD-2010-1240
Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA (2010). «Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer's Disease». Neuro-Degenerative Diseases. 7 (1–3): 38–41. PMID 20160456. doi:10.1159/000283480
Moulton PV, Yang W (2012). «Air Pollution, Oxidative Stress, and Alzheimer's Disease». Journal of Environmental and Public Health. 2012. 472751 páginas. PMID 22523504. doi:10.1155/2012/472751
Kheifets L, Bowman JD, Checkoway H, Feychting M, Harrington JM, Kavet R, Marsh G, Mezei G, Renew DC, van Wijngaarden E (Fevereiro de 2009). «Future needs of occupational epidemiology of extremely low frequency electric and magnetic fields: review and recommendations». Occupational and Environmental Medicine. 66 (2): 72–80. PMID 18805878. doi:10.1136/oem.2007.037994
Braak H, Del Tredici K (Dezembro de 2012). «Where, when, and in what form does sporadic Alzheimer's disease begin?». Current Opinion in Neurology. 25 (Pt 6): 708–14. PMID 23160422. doi:10.1097/WCO.0b013e32835a3432
Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Greve DN, Salat DH, Buckner RL, Fischl B (Agosto de 2009). «Automated MRI Measures Identify Individuals with Mild Cognitive Impairment and Alzheimer's Disease». Brain. 132 (Pt 8): 2048–57. PMC 2714061. PMID 19460794. doi:10.1093/brain/awp123
Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004). «The Importance of Neuritic Plaques and Tangles to the Development and Evolution of AD». Neurology. 62 (11): 1984–9. PMID 15184601. doi:10.1212/01.WNL.0000129697.01779.0A
Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994). «Regional Distribution of Neurofibrillary Tangles and Senile Plaques in the Cerebral Cortex of Elderly Patients: A Quantitative Evaluation of a One-year Autopsy Population from a Geriatric Hospital». Cerebral Cortex. 4 (2): 138–50. PMID 8038565. doi:10.1093/cercor/4.2.138
Kotzbauer PT, Trojanowsk JQ, Lee VM (2001). «Lewy Body Pathology in Alzheimer's Disease». Journal of Molecular Neuroscience. 17 (2): 225–32. PMID 11816795. doi:10.1385/JMN:17:2:225
Hashimoto M, Rockenstein E, Crews L, Masliah E (2003). «Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases». Neuromolecular Medicine. 4 (1–2): 21–36. PMID 14528050. doi:10.1385/NMM:4:1-2:21
Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (2006). «Synapse Formation and Function is Modulated by the Amyloid Precursor Protein». The Journal of Neuroscience. 26 (27): 7212–21. PMID 16822978. doi:10.1523/JNEUROSCI.1450-06.2006
Turner PR, O'Connor K, Tate WP, Abraham WC (2003). «Roles of Amyloid Precursor Protein and its Fragments in Regulating Neural Activity, Plasticity and Memory». Progress in Neurobiology. 70 (1): 1–32. PMID 12927332. doi:10.1016/S0301-0082(03)00089-3
Hooper NM (2005). «Roles of Proteolysis and Lipid Rafts in the Processing of the Amyloid Precursor Protein and Prion Protein». Biochemical Society Transactions. 33 (Pt 2): 335–8. PMID 15787600. doi:10.1042/BST0330335
Ohnishi S, Takano K (2004). «Amyloid Fibrils from the Viewpoint of Protein Folding». Cellular and Molecular Life Sciences. 61 (5): 511–24. PMID 15004691. doi:10.1007/s00018-003-3264-8
Hernández F, Avila J (2007). «Tauopathies». Cellular and Molecular Life Sciences. 64 (17): 2219–33. PMID 17604998. doi:10.1007/s00018-007-7220-x
Van Broeck B, Van Broeckhoven C, Kumar-Singh S (2007). «Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches». Neuro-Degenerative Diseases. 4 (5): 349–65. PMID 17622778. doi:10.1159/000105156
Huang Y, Mucke L (2012). «Alzheimer Mechanisms and Therapeutic strategies». Cell. 148 (6): 1204-22. PMID 22424230. doi:10.1016/j.cell.2012.02.040
Yankner BA, Duffy LK, Kirschner DA (1990). «Neurotrophic and Neurotoxic Effects of Amyloid Beta Protein: Reversal by Tachykinin Neuropeptides». Science. 250 (4978): 279–82. PMID 2218531. doi:10.1126/science.2218531
Chen X, Yan SD (2006). «Mitochondrial Abeta: A Potential Cause of Metabolic Dysfunction in Alzheimer's Disease». IUBMB Life. 58 (12): 686–94. PMID 17424907. doi:10.1080/15216540601047767
Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, Rogers JT, Ovadia H, Lahiri DK (2004). «New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF-alpha Inhibitors, and GLP-1 Receptor Agonists». Annals of the New York Academy of Sciences. 1035: 290–315. PMID 15681814. doi:10.1196/annals.1332.018
Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (2008). «New insights into brain BDNF function in normal aging and Alzheimer disease». Brain Research Reviews. 59 (1): 201–20. PMID 18708092. doi:10.1016/j.brainresrev.2008.07.007
Schindowski K, Belarbi K, Buée L (2008). «Neurotrophic factors in Alzheimer's disease: role of axonal transport». Genes, Brain, and Behavior. 7 (Suppl 1): 43–56. PMC 2228393. PMID 18184369. doi:10.1111/j.1601-183X.2007.00378.x
Mendez MF (2006). «The Accurate Diagnosis of Early-onset Dementia». International Journal of Psychiatry in Medicine. 36 (4): 401–412. PMID 17407994. doi:10.2190/Q6J4-R143-P630-KW41
Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J. Therapeutic Approaches to Alzheimer's Disease. Brain. 2006;129(Pt 11):2840–55. doi:10.1093/brain/awl280. PMID 17018549.
Schroeter ML, Stein T, Maslowski N, Neumann J (2009). «Neural Correlates of Alzheimer's Disease and Mild Cognitive Impairment: A Systematic and Quantitative Meta-Analysis involving 1,351 Patients». NeuroImage. 47 (4): 1196–1206. PMC 2730171. PMID 19463961. doi:10.1016/j.neuroimage.2009.05.037
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). «Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease». Neurology. 34 (7): 939–44. PMID 6610841. doi:10.1212/wnl.34.7.939
Ricardo Nitrini; Paulo Caramelli; Cássio Machado de Campos Bottino; Benito Pereira Damasceno; Sonia Maria Dozzi Brucki; Renato Anghinah (2005). «Diagnóstico de doença de Alzheimer no Brasil: critérios diagnósticos e exames complementares.». Recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Arq. Neuro-Psiquiatr. 63 (3a). doi:10.1590/S0004-282X2005000400033
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007). «Research Criteria for the Diagnosis of Alzheimer's Disease: Revising the NINCDS-ADRDA Criteria». Lancet Neurology. 6 (8): 734–46. PMID 17616482. doi:10.1016/S1474-4422(07)70178-3
Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF (1994). «Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative». Archives of Neurology. 51 (12): 1198–204. PMID 7986174. doi:10.1001/archneur.1994.00540240042014
Pasquier F (1999). «Early diagnosis of dementia: neuropsychology». Journal of Neurology. 246 (1): 6–15. PMID 9987708. doi:10.1007/s004150050299
Harvey PD, Moriarty PJ, Kleinman L, Coyne K, Sadowsky CH, Chen M, Mirski DF (2005). «The Validation of a Caregiver Assessment of Dementia: the Dementia Severity Scale». Alzheimer Disease and Associated Disorders. 19 (4): 186–94. PMID 16327345. doi:10.1097/01.wad.0000189034.43203.60
Antoine C, Antoine P, Guermonprez P, Frigard B (2004). «Awareness of Deficits and Anosognosia in Alzheimer's Disease.». L'Encéphale (em francês). 30 (6): 570–7. PMID 15738860. doi:10.1016/S0013-7006(04)95472-3
Clarfield AM (2003). «The Decreasing Prevalence of Reversible Dementias: An Updated Meta-analysis». Archives of Internal Medicine. 163 (18): 2219–29. PMID 14557220. doi:10.1001/archinte.163.18.2219
Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, Rosenberg I, Mwamburi DM, Qiu WQ (2008). «Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?». Archives of General Psychiatry. 65 (5): 542–550. PMC 3042807. PMID 18458206. doi:10.1001/archpsyc.65.5.542
Potter GG, Steffens DC (2007). «Contribution of Depression to Cognitive Impairment and Dementia in Older adults». The Neurologist. 13 (3): 105–17. PMID 17495754. doi:10.1097/01.nrl.0000252947.15389.a9
Chong MS, Sahadevan S. Preclinical Alzheimer's disease: diagnosis and prediction of progression.. Lancet Neurology. 1 de setembro de 2005;4(9):576–9. doi:10.1016/s1474-4422(05)70168-x. PMID 16109364.
Marksteiner J, Hinterhuber H, Humpel C (2007). «Cerebrospinal Fluid Biomarkers for Diagnosis of Alzheimer's Disease: Beta-amyloid(1–42), Tau, Phospho-tau-181 and Total Protein». Drugs of Today. 43 (6): 423–31. PMID 17612711. doi:10.1358/dot.2007.43.6.1067341
De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ (2010). «Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People». Archives of Neurology. 67 (8): 949–56. PMC 2963067. PMID 20697045. doi:10.1001/archneurol.2010.179
Luchsinger JA, Mayeux R (2004). «Dietary Factors and Alzheimer's Disease». Lancet Neurology. 3 (10): 579–87. PMID 15380154. doi:10.1016/S1474-4422(04)00878-6
Luchsinger JA, Noble JM, Scarmeas N (2007). «Diet and Alzheimer's Disease». Current Neurology and Neuroscience Reports. 7 (5): 366–72. PMID 17764625. doi:10.1007/s11910-007-0057-8
Szekely CA, Breitner JC, Zandi PP (2007). «Prevention of Alzheimer's Disease». International Review of Psychiatry. 19 (6): 693–706. PMID 18092245. doi:10.1080/09540260701797944
Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD (2008). «Diagnosis and Treatment of Dementia: 1. Risk Assessment and Primary Prevention of Alzheimer Disease». Canadian Medical Association Journal. 178 (5): 548–56. PMC 2244657. PMID 18299540. doi:10.1503/cmaj.070796
Rosendorff C, Beeri MS, Silverman JM (2007). «Cardiovascular Risk Factors for Alzheimer's Disease». The American Journal of Geriatric Cardiology. 16 (3): 143–9. PMID 17483665. doi:10.1111/j.1076-7460.2007.06696.x
Reiss AB, Wirkowski E (2007). «Role of HMG-CoA Reductase Inhibitors in Neurological Disorders: Progress to Date». Drugs. 67 (15): 2111–20. PMID 17927279. doi:10.2165/00003495-200767150-00001
Kuller LH (2007). «Statins and Dementia». Current Atherosclerosis Reports. 9 (2): 154–61. PMID 17877925. doi:10.1007/s11883-007-0012-9
Szekely CA, Town T, Zandi PP (2007). «NSAIDs for the Chemoprevention of Alzheimer's Disease». Sub-Cellular Biochemistry. Subcellular Biochemistry. 42: 229–48. ISBN 978-1-4020-5687-1. PMID 17612054. doi:10.1007/1-4020-5688-5_11
Marjoribanks J, Farquhar C, Roberts H, Lethaby A (2012). Farquhar, Cindy, ed. «Long term hormone therapy for perimenopausal and postmenopausal women». The Cochrane Database of Systematic Reviews. 7: CD004143. PMID 22786488. doi:10.1002/14651858.CD004143.pub4
Stern Y (Julho de 2006). «Cognitive reserve and Alzheimer disease». Alzheimer Disease and Associated Disorders. 20 (2): 112–117. ISSN 0893-0341. PMID 16917199. doi:10.1097/01.wad.0000213815.20177.19
Paradise M, Cooper C, Livingston G (2009). «Systematic Review of the Effect of Education on Survival in Alzheimer's Disease». International Psychogeriatrics. 21 (1): 25–32. PMID 19026089. doi:10.1017/S1041610208008053
Fergus I.M. Craik, Ellen Bialystok, Morris Freedman (2010). «Delaying the onset of Alzheimer disease: Bilingualism as a form of cognitive reserve». Neurology. 75 (19): 1726-1729. doi:10.1212/WNL.0b013e3181fc2a1c
Sofi F, Macchi C, Abbate R, Gensini GF, Casini A (2010). «Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer's disease?». Journal of Alzheimer's Disease. 20 (3): 795–801. PMID 20182044. doi:10.3233/JAD-2010-1418
Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Santamato A, Ranieri M, Fiore P, Capurso A, Panza F (2008). «Lifestyle-related Factors in Predementia and Dementia Syndromes». Expert Review of Neurotherapeutics. 8 (1): 133–58. PMID 18088206. doi:10.1586/14737175.8.1.133
Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A (Maio de 2011). «Diet and Alzheimer's disease risk factors or prevention: the current evidence.». Expert Review of Neurotherapeutics. 11 (5): 677–708. PMID 21539488. doi:10.1586/ern.11.56
Kanoski SE, Davidson TL (18 de abril de 2011). «Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity». Physiology & Behavior. 103 (1): 59–68. PMC 3056912. PMID 21167850. doi:10.1016/j.physbeh.2010.12.003
Nehlig A (Julho de 2012). «The neuroprotective effects of cocoa flavanol and its influence on cognitive performance». British Journal of Clinical Pharmacology. 75 (3). PMID 22775434. doi:10.1111/j.1365-2125.2012.04378.x
Stoclet JC, Schini-Kerth V (Março de 2011). «Dietary flavonoids and human health». Annales Pharmaceutiques Françaises. 69 (2): 78–90. PMID 21440100. doi:10.1016/j.pharma.2010.11.004
Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Lorusso M, Santamato A, Seripa D, Pilotto A, Scafato E, Vendemiale G, Capurso A, Solfrizzi V (Maio de 2009). «Alcohol Drinking, Cognitive Functions in Older Age, Predementia, and Dementia Syndromes». Journal of Alzheimer's Disease. 17 (1): 7–31. PMID 19494429. doi:10.3233/JAD-2009-1009
Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N (2010). «Caffeine intake and dementia: systematic review and meta-analysis». Journal of Alzheimer's Disease. 20 Supl 1: S187–204. PMID 20182026. doi:10.3233/JAD-2010-091387
Ono K, Yamada M (Abril de 2012). «Vitamin A and Alzheimer's disease». Geriatrics & Gerontology International. 12 (2): 180–8. PMID 22221326. doi:10.1111/j.1447-0594.2011.00786.x
Lerner AJ, Gustaw-Rothenberg K, Smyth S, Casadesus G (Mar–Abr 2012). «Retinoids for treatment of Alzheimer's disease.». BioFactors. 38 (2): 84–9. PMID 22419567. doi:10.1002/biof.196
Heo JH, Lee KM (Março de 2013). «The possible role of antioxidant vitamin C in Alzheimer's disease treatment and prevention». American Journal of Alzheimer's Disease and Other Dementias. 28 (2): 120–5. PMID 23307795. doi:10.1177/1533317512473193
Boothby LA, Doering PL (2005). «Vitamin C and Vitamin E for Alzheimer's Disease». The Annals of Pharmacotherapy. 39 (12): 2073–80. PMID 16227450. doi:10.1345/aph.1E495
Isaac MG, Quinn R, Tabet N (2008). «Vitamin E for Alzheimer's Disease and Mild Cognitive Impairment». The Cochrane Database of Systematic Reviews (3): CD002854. PMID 18646084. doi:10.1002/14651858.CD002854.pub2
Loef M, Schrauzer GN, Walach H (2011). «Selenium and Alzheimer's disease: a systematic review». Journal of Alzheimer's Disease. 26 (1): 81–104. PMID 21593562. doi:10.3233/JAD-2011-110414
Loef M, von Stillfried N, Walach H (1 de setembro de 2012). «Zinc diet and Alzheimer's disease: a systematic review». Nutritional Neuroscience. 15 (5): 2–12. PMID 22583839. doi:10.1179/1476830512Y.0000000010
Malouf R, Grimley Evans J (2008). «Folic Acid with or without Vitamin B12 for the Prevention and Treatment of Healthy Elderly and Demented people». The Cochrane Database of Systematic Reviews (4): CD004514. PMID 18843658. doi:10.1002/14651858.CD004514.pub2
Wald DS, Kasturiratne A, Simmonds M (Junho de 2010). «Effect of Folic Acid, with or without other B vitamins, on Cognitive Decline: Meta-analysis of Randomized trials». The American Journal of Medicine. 123 (6): 522–527.e2. PMID 20569758. doi:10.1016/j.amjmed.2010.01.017
Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P (Janeiro de 2013). «Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?». Prostaglandins, Leukotrienes, and Essential Fatty Acids. 88 (1): 61–70. PMID 22575581. doi:10.1016/j.plefa.2012.04.006
Hamaguchi T, Ono K, Yamada M (Outubro de 2010). «REVIEW: Curcumin and Alzheimer's disease». CNS Neuroscience & Therapeutics. 16 (5): 285–97. PMID 20406252. doi:10.1111/j.1755-5949.2010.00147.x
Birks J, Grimley Evans J (2009). «Ginkgo Biloba for Cognitive Impairment and Dementia». The Cochrane Database of Systematic Reviews (1): CD003120. PMID 19160216. doi:10.1002/14651858.CD003120.pub3
Krishnan S, Cairns R, Howard R (2009). Krishnan, Sarada, ed. «Cannabinoids for the treatment of dementia». The Cochrane Database of Systematic Reviews (2): CD007204. PMID 19370677. doi:10.1002/14651858.CD007204.pub2
Bilkei-Gorzo A (2012). «The endocannabinoid system in normal and pathological brain ageing». Philos. Trans. R. Soc. Lond., B, Biol. Sci. 367 (1607): 3326–41. PMC 3481530. PMID 23108550. doi:10.1098/rstb.2011.0388
Pohanka M (2011). «Cholinesterases, a target of pharmacology and toxicology» (PDF). Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 155 (3): 219–229. PMID 22286807. doi:10.5507/bp.2011.036
Birks J, Harvey RJ (25 de janeiro de 2006). Birks, Jacqueline, ed. «Donepezil for dementia due to Alzheimer's disease.». The Cochrane Database of Systematic Reviews (1): CD001190. PMID 16437430. doi:10.1002/14651858.CD001190.pub2
Geula C, Mesulam MM (1995). «Cholinesterases and the pathology of Alzheimer disease». Alzheimer Disease and Associated Disorders. 9 Suppl 2: 23–28. PMID 8534419. doi:10.1097/00002093-199501002-00005
Stahl SM (2000). «The new cholinesterase inhibitors for Alzheimer's disease, part 2: illustrating their mechanisms of action». The Journal of Clinical Psychiatry. 61 (11): 813–814. PMID 11105732. doi:10.4088/JCP.v61n1101
Birks J (2006). Birks, Jacqueline, ed. «Cholinesterase inhibitors for Alzheimer's disease». The Cochrane Database of Systematic Reviews (1): CD005593. PMID 16437532. doi:10.1002/14651858.CD005593
Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE (15 de abril de 2009). «Rivastigmine for Alzheimer's disease». The Cochrane Database of Systematic Reviews (2): CD001191. PMID 19370562. doi:10.1002/14651858.CD001191.pub2
Birks J, Harvey RJ (25 de janeiro de 2006). «Donepezil for dementia due to Alzheimer's disease». The Cochrane Database of Systematic Reviews (1): CD001190. PMID 16437430. doi:10.1002/14651858.CD001190.pub2
Raschetti R, Albanese E, Vanacore N, Maggini M (2007). «Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials». PLoS Medicine. 4 (11): e338. PMC 2082649. PMID 18044984. doi:10.1371/journal.pmed.0040338
Birks J (2006). «Cholinesterase inhibitors for Alzheimer's disease». The Cochrane Database of Systematic Reviews (1): CD005593. PMID 16437532. doi:10.1002/14651858.CD005593
Lipton SA (2006). «Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond». Nature Reviews. Drug Discovery. 5 (2): 160–170. PMID 16424917. doi:10.1038/nrd1958
Areosa Sastre A, McShane R, Sherriff F (2004). «Memantine for Dementia». The Cochrane Database of Systematic Reviews (4): CD003154. PMID 15495043. doi:10.1002/14651858.CD003154.pub2
Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M (2008). «Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline». Annals of Internal Medicine. 148 (5): 379–397. PMID 18316756. doi:10.7326/0003-4819-148-5-200803040-00009
Ballard C, Waite J (2006). Ballard, Clive G, ed. «The Effectiveness of Atypical Antipsychotics for the Treatment of Aggression and Psychosis in Alzheimer's Disease». The Cochrane Database of Systematic Reviews (1): CD003476. PMID 16437455. doi:10.1002/14651858.CD003476.pub2
Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu LM, Juszczak E (2008). Brayne, Carol, ed. «A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)». PLoS Medicine. 5 (4): e76. PMC 2276521. PMID 18384230. doi:10.1371/journal.pmed.0050076
Sink KM, Holden KF, Yaffe K (2005). «Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence». JAMA. 293 (5): 596–608. PMID 15687315. doi:10.1001/jama.293.5.596
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R (9 de janeiro de 2009). «The Dementia Antipsychotic Withdrawal Trial (DART-AD): Long-term Follow-up of a Randomised Placebo-controlled Trial». Lancet Neurology. 8 (2): 151–7. PMID 19138567. doi:10.1016/S1474-4422(08)70295-3
Bottino CM, Carvalho IA, Alvarez AM, Avila R, Zukauskas PR, Bustamante SE, Andrade FC, Hototian SR, Saffi F, Câmargo CH (2005). «Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study». Clinical Rehabilitation. 19 (8): 861–869. PMID 16323385. doi:10.1191/0269215505cr911oa
Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL (2001). «Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology». Neurology. 56 (9): 1154–1166. PMID 11342679. doi:10.1212/WNL.56.9.1154
Hermans DG, Htay UH, McShane R (2007). Htay, U Hla, ed. «Non-pharmacological interventions for wandering of people with dementia in the domestic setting». The Cochrane Database of Systematic Reviews (1): CD005994. PMID 17253573. doi:10.1002/14651858.CD005994.pub2
Robinson L, Hutchings D, Dickinson HO, Corner L, Beyer F, Finch T, Hughes J, Vanoli A, Ballard C, Bond J (2007). «Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review». International Journal of Geriatric Psychiatry. 22 (1): 9–22. PMID 17096455. doi:10.1002/gps.1643
Woods B, Spector A, Jones C, Orrell M, Davies S (2005). Woods, Bob, ed. «Reminiscence therapy for dementia». The Cochrane Database of Systematic Reviews (2): CD001120. PMID 15846613. doi:10.1002/14651858.CD001120.pub2
Zetteler J (Novembro de 2008). «Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis». Aging & Mental Health. 12 (6): 779–85. PMID 19023729. doi:10.1080/13607860802380631
Neal M, Briggs M (2003). Neal, Martin, ed. «Validation therapy for dementia». The Cochrane Database of Systematic Reviews (3): CD001394. PMID 12917907. doi:10.1002/14651858.CD001394
Chung JC, Lai CK, Chung PM, French HP (2002). Chung, Jenny CC, ed. «Snoezelen for dementia». The Cochrane Database of Systematic Reviews (4): CD003152. PMID 12519587. doi:10.1002/14651858.CD003152
Spector A, Orrell M, Davies S, Woods B (2000). Spector, Aimee E, ed. «Withdrawn: reality orientation for dementia». The Cochrane Database of Systematic Reviews (3): CD001119. PMID 17636652. doi:10.1002/14651858.CD001119.pub2
Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, Orrell M (2003). «Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial». The British Journal of Psychiatry. 183 (3): 248–254. PMID 12948999. doi:10.1192/bjp.183.3.248
Gitlin LN, Corcoran M, Winter L, Boyce A, Hauck WW (1 de fevereiro de 2001). «A Randomized, Controlled Trial of a Home Environmental Intervention: Effect on Efficacy and Upset in Caregivers and on Daily Function of Persons with Dementia». The Gerontologist. 41 (1): 4–14. PMID 11220813. doi:10.1093/geront/41.1.4 ^{[ligação inativa]}
Gitlin LN, Hauck WW, Dennis MP, Winter L (2005). «Maintenance of Effects of the Home Environmental Skill-building Program for Family Caregivers and Individuals with Alzheimer's Disease and Related Disorders». The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 60 (3): 368–74. PMID 15860476. doi:10.1093/gerona/60.3.368
Dunne TE, Neargarder SA, Cipolloni PB, Cronin-Golomb A (2004). «Visual Contrast Enhances Food and Liquid Intake in Advanced Alzheimer's Disease». Clinical Nutrition (Edinburgh, Scotland). 23 (4): 533–538. PMID 15297089. doi:10.1016/j.clnu.2003.09.015
Sampson EL, Candy B, Jones L (2009). «Enteral tube feeding for older people with advanced dementia (Intervention Review)». The Cochrane Library (2). doi:10.1002/14651858.CD007209.pub2
Chernoff R (2006). «Tube Feeding Patients with Dementia». Nutrition in Clinical Practice. 21 (2): 142–6. PMID 16556924. doi:10.1177/0115426506021002142
Gambassi G, Landi F, Lapane KL, Sgadari A, Mor V, Bernabei R (1999). «Predictors of Mortality in Patients with Alzheimer's Disease Living in Nursing Homes». Journal of Neurology, Neurosurgery, and Psychiatry. 67 (1): 59–65. PMC 1736445. PMID 10369823. doi:10.1136/jnnp.67.1.59
Problemas de saúde:
- Head B (2003). «Palliative Care for Persons with Dementia». Home Healthcare Nurse. 21 (1): 53–61. PMID 12544465. doi:10.1097/00004045-200301000-00012
- Shega JW, Levin A, Hougham GW, Cox-Hayley D, Luchins D, Hanrahan P, Stocking C, Sachs GA (2003). «Palliative Excellence in Alzheimer Care Efforts (PEACE): A Program Description». Journal of Palliative Medicine. 6 (2): 315–20. PMID 12854952. doi:10.1089/109662103764978641
- Mölsä PK, Marttila RJ, Rinne UK (1986). «Survival and Cause of Death in Alzheimer's Disease and Multi-Infarct Dementia». Acta Neurologica Scandinavica. 74 (2): 103–7. PMID 3776457. doi:10.1111/j.1600-0404.1986.tb04634.x
- Dodge HH, Shen C, Pandav R, DeKosky ST, Ganguli M (2003). «Functional Transitions and Active Life Expectancy Associated with Alzheimer Disease». Archives of Neurology. 60 (2): 253–9. PMID 12580712. doi:10.1001/archneur.60.2.253
- Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST (2005). «Alzheimer Disease and Mortality: A 15-year Epidemiological Study». Archives of Neurology. 62 (5): 779–84. PMID 15883266. doi:10.1001/archneur.62.5.779
- Jagger C, Clarke M, Stone A (1995). «Predictors of Survival with Alzheimer's Disease: A Community-based Study». Psychological Medicine. 25 (1): 171–7. PMID 7792352. doi:10.1017/S0033291700028191
- Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC (2008). «Incidence and subtypes of dementia in three elderly populations of central Spain». Journal of the Neurological Sciences. 264 (1–2): 63–72. PMID 17727890. doi:10.1016/j.jns.2007.07.021
- Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G, Inzitari D (2002). «Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study». Journal of the American Geriatrics Society. 50 (1): 41–8. PMID 12028245. doi:10.1046/j.1532-5415.2002.50006.x
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003). «Alzheimer Disease in the US population: Prevalence Estimates Using the 2000 census». Archives of Neurology. 60 (8): 1119–22. PMID 12925369. doi:10.1001/archneur.60.8.1119
- Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005). «Global Prevalence of Dementia: A Delphi Consensus Study». Lancet. 366 (9503): 2112–7. PMC 2850264. PMID 16360788. doi:10.1016/S0140-6736(05)67889-0
- Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007). «Forecasting the global burden of Alzheimer's disease». Alzheimer's & Dementia. 3 (3): 186–91. PMID 19595937. doi:10.1016/j.jalz.2007.04.381
- Berchtold NC, Cotman CW (1998). «Evolution in the Conceptualization of Dementia and Alzheimer's Disease: Greco-Roman Period to the 1960s». Neurobiology of Aging. 19 (3): 173–89. PMID 9661992. doi:10.1016/S0197-4580(98)00052-9
- Berrios G E (1990). «Alzheimer's Disease: A Conceptual History». Int. J. Ger. Psychiatry. 5 (6): 355–365. doi:10.1002/gps.930050603
- Boller F, Forbes MM (1998). «History of Dementia and Dementia in History: An Overview». Journal of the Neurological Sciences. 158 (2): 125–33. PMID 9702682. doi:10.1016/S0022-510X(98)00128-2
- Allegri RF, Butman J, Arizaga RL, Machnicki G, Serrano C, Taragano FE, Sarasola D, Lon L (2007). «Economic Impact of Dementia in Developing Countries: An Evaluation of Costs of Alzheimer-type Dementia in Argentina». International Psychogeriatrics. 19 (4): 705–18. PMID 16870037. doi:10.1017/S1041610206003784
- Suh GH, Knapp M, Kang CJ (2006). «The Economic Costs of Dementia in Korea, 2002». International Journal of Geriatric Psychiatry. 21 (8): 722–8. PMID 16858741. doi:10.1002/gps.1552
- Wimo A, Jonsson L, Winblad B (2006). «An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003». Dementia and Geriatric Cognitive Disorders. 21 (3): 175–81. PMID 16401889. doi:10.1159/000090733
- Moore MJ, Zhu CW, Clipp EC (2001). «Informal Costs of Dementia Care: Estimates from the National Longitudinal Caregiver Study». The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 56 (4): S219–28. PMID 11445614. doi:10.1093/geronb/56.4.S219
- Jönsson L, Eriksdotter Jönhagen M, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A (2006). «Determinants of Costs of Care for Patients with Alzheimer's Disease». International Journal of Geriatric Psychiatry. 21 (5): 449–59. PMID 16676288. doi:10.1002/gps.1489
- Schneider J, Murray J, Banerjee S, Mann A (1999). «EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I—Factors associated with carer burden». International Journal of Geriatric Psychiatry. 14 (8): 651–661. PMID 10489656. doi:10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B
- Murray J, Schneider J, Banerjee S, Mann A (1999). «EUROCARE: A Cross-National Study of Co-resident Spouse Carers for People with Alzheimer's Disease: II—A Qualitative Analysis of the Experience of Caregiving». International Journal of Geriatric Psychiatry. 14 (8): 662–7. PMID 10489657. doi:10.1002/(SICI)1099-1166(199908)14:8<662::AID-GPS993>3.0.CO;2-4
- Zhu CW, Sano M (2006). «Economic Considerations in the Management of Alzheimer's Disease». Clinical Interventions in Aging. 1 (2): 143–54. PMC 2695165. PMID 18044111. doi:10.2147/ciia.2006.1.2.143
- Gaugler JE, Kane RL, Kane RA, Newcomer R (2005). «Early Community-based Service Utilization and Its Effects on Institutionalization in Dementia Caregiving». The Gerontologist. 45 (2): 177–85. PMID 15799982. doi:10.1093/geront/45.2.177
- Ritchie K, Lovestone S (2002). «The Dementias». Lancet. 360 (9347): 1759–66. PMID 12480441. doi:10.1016/S0140-6736(02)11667-9
- Brodaty H, Hadzi-Pavlovic D (1990). «Psychosocial Effects on Carers of Living with Persons with Dementia». The Australian and New Zealand Journal of Psychiatry. 24 (3): 351–61. PMID 2241719. doi:10.3109/00048679009077702
- Donaldson C, Tarrier N, Burns A (1998). «Determinants of Carer Stress in Alzheimer's Disease». International Journal of Geriatric Psychiatry. 13 (4): 248–56. PMID 9646153. doi:10.1002/(SICI)1099-1166(199804)13:4<248::AID-GPS770>3.0.CO;2-0
- Pusey H, Richards D (2001). «A Systematic Review of the Effectiveness of Psychosocial Interventions for Carers of People with Dementia». Aging & Mental Health. 5 (2): 107–19. PMID 11511058. doi:10.1080/13607860120038302
- Lashuel HA, Hartley DM, Balakhaneh D, Aggarwal A, Teichberg S, Callaway DJ (2002). «New Class of Inhibitors of Beta-amyloid Fibril Formation. Implications for the Mechanism of Pathogenesis in Alzheimer's Disease». The Journal of Biological Chemistry. 277 (45): 42881–42890. PMID 12167652. doi:10.1074/jbc.M206593200
- Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W (2010). «Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence». Drugs. 70 (5): 513–528. PMID 20329802. doi:10.2165/11533070-000000000-00000. Consultado em 22 de novembro de 2014. Arquivado do original em 17 de setembro de 2011
- Vacinação:
  - Hawkes CA, McLaurin J (2007). «Immunotherapy as Treatment for Alzheimer's Disease». Expert Review of Neurotherapeutics. 7 (11): 1535–48. PMID 17997702. doi:10.1586/14737175.7.11.1535
  - Investigação relativa ao etanercepte:
    - Tobinick E (setembro de 2009). «Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence». CNS Drugs. 23 (9): 713-25. PMID 19689163. doi:10.2165/11310810-000000000-00000
    - Martin C, Solís L, Concha MI, Otth C (Junho de 2011). «Herpes simplex virus tipo 1 como factor de riesgo asociado con la enfermedad de Alzheimer». Revista Médica De Chile. 139 (6): 779–86. PMID 22051760. doi:10.4067/S0034-98872011000600013
    - Wozniak MA, Mee AP, Itzhaki RF (2008). «Herpes Simplex Virus type 1 DNA Is Located within Alzheimer's Disease Amyloid Plaques». The Journal of Pathology. 217 (1): 131–138. PMID 18973185. doi:10.1002/path.2449
    - Wischik Claude M, Bentham Peter, Wischik Damon J, Seng Kwang Meng (2008). «Tau aggregation inhibitor (TAI) therapy with remberTM arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks». Alzheimer's Association. Alzheimer's & Dementia. 4 (4): T167. doi:10.1016/j.jalz.2008.05.438
    - Harrington Charles (2008). «Methylthioninium chloride (MTC) acts as a tau aggregation inhibitor (TAI) in a cellular model and reverses tau pathology in transgenic mouse models of Alzheimer's disease». Alzheimer's Association. Alzheimer's & Dementia. 4 (4): T120–T121. doi:10.1016/j.jalz.2008.05.259
    - Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D (2008). «Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study». Lancet. 372 (9634): 207–15. PMID 18640457. doi:10.1016/S0140-6736(08)61074-0
    - Bezprozvanny I (Outubro de 2010). «The rise and fall of Dimebon». Drug News & Perspectives. 23 (8): 518–23. PMID 21031168. doi:10.1358/dnp.2010.23.8.1500435
    - Wendler A, Wehling M (2012). «Translatability scoring in drug development: eight case studies». Journal of Translational Medicine. 10 (10): 39. PMID 22397594. doi:10.1186/1479-5876-10-39
    - Baddeley TC, McCaffrey J, Storey JM, Cheung JK, Melis V, Horsley D, Harrington CR, Wischik CM (15 de outubro de 2014). «Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease». J Pharmacol Exp Ther. PMID 25320049. doi:10.1124/jpet.114.219352
    - Wischik CM, Harrington CR, Storey JM (15 de abril de 2014). «Tau-aggregation inhibitor therapy for Alzheimer's disease». Biochem Pharmacol. 88 (4): 529-39. PMID 24361915. doi:10.1016/j.bcp.2013.12.008
    - Dougall NJ, Bruggink S, Ebmeier KP (2004). «Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia». The American Journal of Geriatric Psychiatry. 12 (6): 554–70. PMID 15545324. doi:10.1176/appi.ajgp.12.6.554
    - O'Brien JT (Dezembro de 2007). «Role of Imaging Techniques in the Diagnosis of Dementia». The British Journal of Radiology. 80 (Spec No 2): S71–7. PMID 18445747. doi:10.1259/bjr/33117326
    - Bellaver B, Povala G, Ferreira PL, Ferrari-Souza JP, Leffa DT, Lussier FZ, et al. (Maio de 2023). «Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease». Nature Medicine. doi:10.1038/s41591-023-02380-x

europa.eu

ec.europa.eu

Scientific Committee on Emerging and Newly Identified Health Risks-SCENIHR (Janeiro de 2009). «Health Effects of Exposure to EMF» (PDF). Brussels: Directorate General for Health&Consumers; European Commission: 4–5

fda.gov

«Information for Healthcare Professionals: Conventional Antipsychotics». US Food and Drug Administration. 16 de junho de 2008. Consultado em 29 de novembro de 2014. Cópia arquivada em 29 de novembro de 2014
«FDA Grants Accelerated Approval for Alzheimer's Drug». Food and Drug Administration. 7 de junho de 2021. Consultado em 7 de junho de 2021

frx.com

«Namenda prescribing information» (PDF). Forest Pharmaceuticals. Consultado em 19 de fevereiro de 2008. Arquivado do original (PDF) em 27 de fevereiro de 2008

gerontologyjournals.org

gerontologist.gerontologyjournals.org

Gitlin LN, Corcoran M, Winter L, Boyce A, Hauck WW (1 de fevereiro de 2001). «A Randomized, Controlled Trial of a Home Environmental Intervention: Effect on Efficacy and Upset in Caregivers and on Daily Function of Persons with Dementia». The Gerontologist. 41 (1): 4–14. PMID 11220813. doi:10.1093/geront/41.1.4 ^{[ligação inativa]}

jbc.org

Lashuel HA, Hartley DM, Balakhaneh D, Aggarwal A, Teichberg S, Callaway DJ (2002). «New Class of Inhibitors of Beta-amyloid Fibril Formation. Implications for the Mechanism of Pathogenesis in Alzheimer's Disease». The Journal of Biological Chemistry. 277 (45): 42881–42890. PMID 12167652. doi:10.1074/jbc.M206593200

kurzweilai.net

Patients and researchers collaborate to find medical cures em "KurzweilAI" (2008)

medcitynews.com

3 neat ways to participate in crowdsourced cancer and Alzheimer’s disease research 3 jeitos

medivation.com

investors.medivation.com

«Pfizer And Medivation announce results from two phase 3 studies in Dimebon (latrepirdine*) Alzheimer's disease clinical development program (NASDAQ:MDVN)». Consultado em 16 de novembro de 2012. Arquivado do original em 4 de setembro de 2012

metapress.com

iospress.metapress.com

Itzhaki RF, Wozniak MA (2008). «Herpes Simplex Virus Type 1 in Alzheimer's Disease: The Enemy Within». Journal of Alzheimer's Disease. 13 (4): 393–405. ISSN 1387-2877. PMID 18487848

metlife.com

«The MetLife study of Alzheimer's disease: The caregiving experience» (PDF). MetLife Mature Market Institute. Agosto de 2006. Consultado em 5 de Fevereiro de 2011. Arquivado do original (PDF) em 8 de janeiro de 2011

mit.edu

news.mit.edu

Unique visual stimulation may be new treatment for Alzheimer’sNoninvasive technique reduces beta amyloid plaques in mouse models of Alzheimer’s disease. por Anne Trafton, publicado pelo "MIT News Office" (2016)

neurology.org

Fergus I.M. Craik, Ellen Bialystok, Morris Freedman (2010). «Delaying the onset of Alzheimer disease: Bilingualism as a form of cognitive reserve». Neurology. 75 (19): 1726-1729. doi:10.1212/WNL.0b013e3181fc2a1c

nice.org.uk

National Institute for Health and Clinical Excellence. «Low-dose antipsychotics in people with dementia». National Institute for Health and Care Excellence (NICE). Consultado em 29 de novembro de 2014. Arquivado do original em 5 de dezembro de 2014
Dementia: Quick Reference Guide (PDF). London: National Institute for Health and Clinical Excellence. Novembro de 2006. ISBN 1-84629-312-X. Consultado em 9 de outubro de 2014. Arquivado do original (PDF) em 27 de fevereiro de 2008

pathways.nice.org.uk

«Dementia diagnosis and assessment» (PDF). National Institute for Health and Care Excellence (NICE). Consultado em 30 de novembro de 2014. Cópia arquivada (PDF) em 5 de dezembro de 2014

nih.gov

ncbi.nlm.nih.gov

Burns A, Iliffe S (fevereiro de 2009). «Alzheimer's disease». BMJ. 338: b158. ISSN 0959-8138. PMID 19196745. doi:10.1136/bmj.b158. (pede subscrição (ajuda))
Mendez MF (novembro de 2012). «Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD». Archives of Medical Research. 43 (8): 677–85. PMC 3532551. PMID 23178565. doi:10.1016/j.arcmed.2012.11.009
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (março de 2011). «Alzheimer's disease». Lancet. 377 (9770): 1019–31. PMID 21371747. doi:10.1016/S0140-6736(10)61349-9
Commission de la transparence. Médicaments de la maladie d'Alzheimer [Drugs for Alzheimer's disease: best avoided. No therapeutic advantage]. Prescrire International. June 2012;21(128):150. PMID 22822592.
Querfurth HW, LaFerla FM (janeiro de 2010). «Alzheimer's disease». The New England Journal of Medicine. 362 (4): 329–44. PMID 20107219. doi:10.1056/NEJMra0909142
«Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1545–1602. Outubro de 2016. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
«Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1459–1544. Outubro de 2016. PMC 5388903. PMID 27733281. doi:10.1016/S0140-6736(16)31012-1
Todd S, Barr S, Roberts M, Passmore AP (novembro de 2013). «Survival in dementia and predictors of mortality: a review». International Journal of Geriatric Psychiatry. 28 (11): 1109–24. PMID 23526458. doi:10.1002/gps.3946
Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward. Current Alzheimer research. 2017;14(4):426-440. doi:10.2174/1567205013666160930112125. PMID 27697063.
Systematic Review of Information and Support Interventions for Caregivers of People with Dementia. BMC Geriatrics. 2007;7:18. doi:10.1186/1471-2318-7-18. PMID 17662119.
Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S (abril de 2015). «Exercise programs for people with dementia». The Cochrane Database of Systematic Reviews (4): CD006489. PMID 25874613. doi:10.1002/14651858.CD006489.pub4
Evolution in the Conceptualization of Dementia and Alzheimer's Disease: Greco-Roman Period to the 1960s. Neurobiology of Aging. 1998;19(3):173–89. doi:10.1016/S0197-4580(98)00052-9. PMID 9661992.
Impact économique de la démence (English: The Economical Impact of Dementia). Presse Médicale. 2005;34(1):35–41. French. doi:10.1016/s0755-4982(05)83882-5. PMID 15685097.
Economic Considerations in Alzheimer's Disease. Pharmacotherapy. 1998;18(2 Pt 2):68–73; discussion 79–82. doi:10.1002/j.1875-9114.1998.tb03880.x. PMID 9543467.
Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B (2007). «Recommendations for the Diagnosis and Management of Alzheimer's Disease and Other Disorders Associated with Dementia: EFNS Guideline». European Journal of Neurology. 14 (1): e1–26. PMID 17222085. doi:10.1111/j.1468-1331.2006.01605.x
Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ (2004). «Multiple Cognitive Deficits During the Transition to Alzheimer's Disease». Journal of Internal Medicine. 256 (3): 195–204. PMID 15324363. doi:10.1111/j.1365-2796.2004.01386.x
Nygård L (2003). «Instrumental Activities of Daily Living: A Stepping-stone Towards Alzheimer's Disease Diagnosis in Subjects with Mild Cognitive Impairment?». Acta Neurologica Scandinavica. Suppl (179): 42–6. PMID 12603250. doi:10.1034/j.1600-0404.107.s179.8.x
Arnáiz E, Almkvist O (2003). «Neuropsychological Features of Mild Cognitive Impairment and Preclinical Alzheimer's Disease». Acta Neurologica Scandinavica. 179: 34–41. PMID 12603249. doi:10.1034/j.1600-0404.107.s179.7.x
Landes AM, Sperry SD, Strauss ME, Geldmacher DS (2001). «Apathy in Alzheimer's Disease». Journal of the American Geriatrics Society. 49 (12): 1700–7. PMID 11844006. doi:10.1046/j.1532-5415.2001.49282.x
Petersen RC (2007). «The Current Status of Mild Cognitive Impairment—What Do We Tell Our Patients?». Nature Clinical Practice. Neurology. 3 (2): 60–1. PMID 17279076. doi:10.1038/ncpneuro0402
Förstl H, Kurz A (1999). «Clinical Features of Alzheimer's Disease». European Archives of Psychiatry and Clinical Neuroscience. 249 (6): 288–290. PMID 10653284. doi:10.1007/s004060050101
Carlesimo GA, Oscar-Berman M (1992). «Memory Deficits in Alzheimer's Patients: A Comprehensive Review». Neuropsychology Review. 3 (2): 119–69. PMID 1300219. doi:10.1007/BF01108841
Jelicic M, Bonebakker AE, Bonke B (1995). «Implicit Memory Performance of Patients with Alzheimer's Disease: A Brief Review». International Psychogeriatrics. 7 (3): 385–392. PMID 8821346. doi:10.1017/S1041610295002134
Taler V, Phillips NA (Julho de 2008). «Language Performance in Alzheimer's Disease and Mild Cognitive Impairment: a comparative review». Journal of Clinical and Experimental Neuropsychology. 30 (5): 501–56. PMID 18569251. doi:10.1080/13803390701550128
Frank EM (1994). «Effect of Alzheimer's Disease on Communication Function». Journal of the South Carolina Medical Association. 90 (9): 417–23. PMID 7967534
Gold DP, Reis MF, Markiewicz D, Andres D (1995). «When Home Caregiving Ends: A Longitudinal Study of Outcomes for Caregivers of Relatives with Dementia». Journal of the American Geriatrics Society. 43 (1): 10–6. PMID 7806732
Wilson RS, Barral S, Lee JH, Leurgans SE, Foroud TM, Sweet RA, Graff-Radford N, Bird TD, Mayeux R, Bennett DA (2011). «Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study.». J Alzheimers Dis. 23 (2): 249-55. PMID 20930268. doi:10.3233/JAD-2010-101515
Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL (2006). «Role of genes and environments for explaining Alzheimer disease». Arch Gen Psychiatry. 63 (2): 168-74. PMID 16461860. doi:10.1001/archpsyc.63.2.168
Blennow K, de Leon MJ, Zetterberg H (2006). «Alzheimer's Disease». Lancet. 368 (9533): 387–403. PMID 16876668. doi:10.1016/S0140-6736(06)69113-7
Waring SC, Rosenberg RN (2008). «Genome-wide association studies in Alzheimer disease». Archives of Neurology. 65 (3): 329–34. PMID 18332245. doi:10.1001/archneur.65.3.329
Selkoe DJ (1999). «Translating cell biology into therapeutic advances in Alzheimer's disease». Nature. 399 (6738 Suppl): A23–31. PMID 10392577. doi:10.1038/19866
Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS (1996). «Familial Alzheimer's disease-linked presenilin 1 variants elevate βA1-42/1-40 ratio in vitro and in vivo». Neuron. 17 (5): 1005–13. PMID 8938131. doi:10.1016/S0896-6273(00)80230-5
Shioi J, Georgakopoulos A, Mehta P, Kouchi Z, Litterst CM, Baki L, Robakis NK (2007). «FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta». Journal of Neurochemistry. 101 (3): 674–81. PMID 17254019. doi:10.1111/j.1471-4159.2006.04391.x
Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K (2 de agosto de 2012). «A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.». Nature. 488 (7409): 96–9. PMID 22801501. doi:10.1038/nature11283
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993). «Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease». Proceedings of the National Academy of Sciences of the United States of America. 90 (5): 1977–81. PMC 46003. PMID 8446617. doi:10.1073/pnas.90.5.1977
Mahley RW, Weisgraber KH, Huang Y (2006). «Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease». Proceedings of the National Academy of Sciences of the United States of America. 103 (15): 5644–51. PMC 1414631. PMID 16567625. doi:10.1073/pnas.0600549103
Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H (2006). «Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba». Neurology. 66 (2): 223–227. PMC 2860622. PMID 16434658. doi:10.1212/01.wnl.0000194507.39504.17
Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, Smith-Gamble V, Lane KA, Gao S, Hall KS, Hendrie HC, Murrell JR (2006). «APOE ε4 is not associated with Alzheimer's disease in elderly Nigerians». Annals of Neurology. 59 (1): 182–185. PMC 2855121. PMID 16278853. doi:10.1002/ana.20694
Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K (2012). «Variant of TREM2 associated with the risk of Alzheimer's disease». The New England Journal of Medicine (Original article). 368 (2): 107–16. PMC 3677583. PMID 23150908. doi:10.1056/NEJMoa1211103
Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J (2012). «TREM2 variants in Alzheimer's disease». The New England Journal of Medicine (Original article). 368 (2): 117–27. PMC 3631573. PMID 23150934. doi:10.1056/NEJMoa1211851
Lambert, JC (2013). «Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.». Nature Genetics. 45 (12): 1452–8. PMC 3896259. PMID 24162737. doi:10.1038/ng.2802
Francis PT, Palmer AM, Snape M, Wilcock GK (1999). «The Cholinergic Hypothesis of Alzheimer's Disease: a Review of Progress». Journal of Neurology, Neurosurgery, and Psychiatry. 66 (2): 137–47. PMC 1736202. PMID 10071091. doi:10.1136/jnnp.66.2.137
Shen ZX (2004). «Brain Cholinesterases: II. The Molecular and Cellular Basis of Alzheimer's Disease». Medical Hypotheses. 63 (2): 308–21. PMID 15236795. doi:10.1016/j.mehy.2004.02.031
Wenk GL (2003). «Neuropathologic Changes in Alzheimer's Disease». The Journal of Clinical Psychiatry. 64 Suppl 9: 7–10. PMID 12934968
Hardy J, Allsop D (1991). «Amyloid Deposition as the Central Event in the Aetiology of Alzheimer's Disease». Trends in Pharmacological Sciences. 12 (10): 383–88. PMID 1763432. doi:10.1016/0165-6147(91)90609-V
Mudher A, Lovestone S (2002). «Alzheimer's disease-do tauists and baptists finally shake hands?». Trends in Neurosciences. 25 (1): 22–26. PMID 11801334. doi:10.1016/S0166-2236(00)02031-2
Nistor M, Don M, Parekh M, Sarsoza F, Goodus M, Lopez GE, Kawas C, Leverenz J, Doran E, Lott IT, Hill M, Head E (2007). «Alpha- and Beta-secretase Activity as a Function of Age and Beta-amyloid in Down Syndrome and Normal Brain». Neurobiology of Aging. 28 (10): 1493–1506. PMC 3375834. PMID 16904243. doi:10.1016/j.neurobiolaging.2006.06.023
Lott IT, Head E (2005). «Alzheimer Disease and Down Syndrome: Factors in Pathogenesis». Neurobiology of Aging. 26 (3): 383–89. PMID 15639317. doi:10.1016/j.neurobiolaging.2004.08.005
Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K (1995). «Apolipoprotein E, Dementia, and Cortical Deposition of Beta-amyloid Protein». The New England Journal of Medicine. 333 (19): 1242–47. PMID 7566000. doi:10.1056/NEJM199511093331902
Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F (1995). «Alzheimer-type Neuropathology in Transgenic Mice Overexpressing V717F Beta-amyloid Precursor Protein». Nature. 373 (6514): 523–27. PMID 7845465. doi:10.1038/373523a0
Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D (1996). «Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F Beta-amyloid Precursor Protein and Alzheimer's Disease». The Journal of Neuroscience. 16 (18): 5795–811. PMID 8795633
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996). «Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice». Science. 274 (5284): 99–102. PMID 8810256. doi:10.1126/science.274.5284.99
Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C, Strazielle C (2002). «Spatial Learning, Exploration, Anxiety, and Motor Coordination in Female APP23 Transgenic Mice with the Swedish Mutation». Brain Research. 956 (1): 36–44. PMID 12426044. doi:10.1016/S0006-8993(02)03476-5
Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008). «Long-term Effects of Abeta42 Immunisation in Alzheimer's Disease: Follow-up of a Randomised, Placebo-controlled Phase I Trial». Lancet. 372 (9634): 216–23. PMID 18640458. doi:10.1016/S0140-6736(08)61075-2
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007). «Aß Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease». The Journal of Neuroscience. 27 (4): 796–807. PMID 17251419. doi:10.1523/JNEUROSCI.3501-06.2007
Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009). «Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers». Nature. 457 (7233): 1128–32. PMC 2748841. PMID 19242475. doi:10.1038/nature07761
Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M (19 de fevereiro de 2009). «APP Binds DR6 to Cause Axon Pruning and Neuron Death via Distinct Caspases». Nature. 457 (7232): 981–989. ISSN 0028-0836. PMC 2677572. PMID 19225519. doi:10.1038/nature07767
Goedert M, Spillantini MG, Crowther RA (1991). «Tau Proteins and Neurofibrillary Degeneration». Brain Pathology (Zurich, Switzerland). 1 (4): 279–86. PMID 1669718. doi:10.1111/j.1750-3639.1991.tb00671.x
Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005). «Tau Pathology in Alzheimer Disease and Other Tauopathies». Biochimica Et Biophysica Acta. 1739 (2–3): 198–210. PMID 15615638. doi:10.1016/j.bbadis.2004.09.008
Chun W, Johnson GV (2007). «The Role of Tau Phosphorylation and Cleavage in Neuronal Cell Death». Frontiers in Bioscience: A Journal and Virtual Library. 12: 733–56. PMID 17127334. doi:10.2741/2097
Xu H, Finkelstein DI, Adlard PA (12 de junho de 2014). «Interactions of metals and Apolipoprotein E in Alzheimer's disease». Front Aging Neurosci. 6. 121 páginas. PMC 4054654. PMID 24971061. doi:10.3389/fnagi.2014.00121. Although we still do not know if the metal ion dyshomeostasis present in AD is a cause or consequence of the disease, there is a growing body of evidence showing a direct correlation between metal ions and key AD-related key proteins.
Shcherbatykh I, Carpenter DO (2007). «The Role of Metals in the Etiology of Alzheimer's Disease». Journal of Alzheimer's Disease. 11 (2): 191–205. PMID 17522444
Santibáñez M, Bolumar F, García AM (2007). «Occupational Risk Factors in Alzheimer's Disease: A Review Assessing the Quality of Published Epidemiological Studies». Occupational and Environmental Medicine. 64 (11): 723–732. PMC 2078415. PMID 17525096. doi:10.1136/oem.2006.028209
Rondeau V (2002). «A Review of Epidemiologic Studies on Aluminum and Silica in Relation to Alzheimer's Disease and Associated Disorders». Reviews on Environmental Health. 17 (2): 107–21. PMID 12222737. doi:10.1515/REVEH.2002.17.2.107
Brewer GJ (Março de 2012). «Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease». BioFactors (Oxford, England). 38 (2): 107–113. PMID 22438177. doi:10.1002/biof.1005
Bartzokis G (Agosto de 2011). «Alzheimer's Disease as Homeostatic Responses to Age-related Myelin Breakdown». Neurobiology of Aging. 32 (8): 1341–71. PMC 3128664. PMID 19775776. doi:10.1016/j.neurobiolaging.2009.08.007
Bartzokis G, Lu PH, Mintz J (Dezembro de 2004). «Quantifying Age-Related Myelin Breakdown with MRI: Novel Therapeutic Targets for Preventing Cognitive Decline and Alzheimer's Disease». Journal of Alzheimer's Disease. 6 (6 Suppl): S53–9. PMID 15665415
Bartzokis G, Lu PH, Mintz J (Abril de 2007). «Human Brain Myelination and Beta-amyloid Deposition in Alzheimer's Disease». Alzheimer's & Dementia. 3 (2): 122–5. PMC 2442864. PMID 18596894. doi:10.1016/j.jalz.2007.01.019
Itzhaki RF, Wozniak MA (2008). «Herpes Simplex Virus Type 1 in Alzheimer's Disease: The Enemy Within». Journal of Alzheimer's Disease. 13 (4): 393–405. ISSN 1387-2877. PMID 18487848
Su B, Wang X, Nunomura A, Moreira PI, Lee HG, Perry G, Smith MA, Zhu X (Dezembro de 2008). «Oxidative Stress Signaling in Alzheimer's Disease». Current Alzheimer Research. 5 (6): 525–32. PMC 2780015. PMID 19075578. doi:10.2174/156720508786898451
Kastenholz B, Garfin DE, Horst J, Nagel KA (2009). «Plant Metal Chaperones: A Novel Perspective in Dementia Therapy». Amyloid: The International Journal of Experimental and Clinical Investigation: The Official Journal of the International Society of Amyloidosis. 16 (2): 81–3. PMID 20536399. doi:10.1080/13506120902879392
Pohanka M (2013). «Alzheimer´s Disease and Oxidative Stress: A Review». Current Medicinal Chemistry (Review). 21 (3): 356–64. PMID 24059239. doi:10.2174/09298673113206660258
Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, Jardanhazi-Kurutz D, Walter J, Kirchhoff F, Hanisch UK, Kummer MP. (2010). «Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine» (PDF). Proceedings of the National Academy of Sciences of the United States of America. 107: 6058–6063. PMID 20231476. doi:10.1073/pnas.0909586107
Cataldo JK, Prochaska JJ, Glantz SA (2010). «Cigarette smoking is a risk factor for Alzheimer's disease: An analysis controlling for tobacco industry affiliation». Journal of Alzheimer's Disease. 19 (2): 465–80. PMC 2906761. PMID 20110594. doi:10.3233/JAD-2010-1240
Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA (2010). «Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer's Disease». Neuro-Degenerative Diseases. 7 (1–3): 38–41. PMID 20160456. doi:10.1159/000283480
Moulton PV, Yang W (2012). «Air Pollution, Oxidative Stress, and Alzheimer's Disease». Journal of Environmental and Public Health. 2012. 472751 páginas. PMID 22523504. doi:10.1155/2012/472751
Kheifets L, Bowman JD, Checkoway H, Feychting M, Harrington JM, Kavet R, Marsh G, Mezei G, Renew DC, van Wijngaarden E (Fevereiro de 2009). «Future needs of occupational epidemiology of extremely low frequency electric and magnetic fields: review and recommendations». Occupational and Environmental Medicine. 66 (2): 72–80. PMID 18805878. doi:10.1136/oem.2007.037994
Braak H, Del Tredici K (Dezembro de 2012). «Where, when, and in what form does sporadic Alzheimer's disease begin?». Current Opinion in Neurology. 25 (Pt 6): 708–14. PMID 23160422. doi:10.1097/WCO.0b013e32835a3432
Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Greve DN, Salat DH, Buckner RL, Fischl B (Agosto de 2009). «Automated MRI Measures Identify Individuals with Mild Cognitive Impairment and Alzheimer's Disease». Brain. 132 (Pt 8): 2048–57. PMC 2714061. PMID 19460794. doi:10.1093/brain/awp123
Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004). «The Importance of Neuritic Plaques and Tangles to the Development and Evolution of AD». Neurology. 62 (11): 1984–9. PMID 15184601. doi:10.1212/01.WNL.0000129697.01779.0A
Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH (1994). «Regional Distribution of Neurofibrillary Tangles and Senile Plaques in the Cerebral Cortex of Elderly Patients: A Quantitative Evaluation of a One-year Autopsy Population from a Geriatric Hospital». Cerebral Cortex. 4 (2): 138–50. PMID 8038565. doi:10.1093/cercor/4.2.138
Kotzbauer PT, Trojanowsk JQ, Lee VM (2001). «Lewy Body Pathology in Alzheimer's Disease». Journal of Molecular Neuroscience. 17 (2): 225–32. PMID 11816795. doi:10.1385/JMN:17:2:225
Hashimoto M, Rockenstein E, Crews L, Masliah E (2003). «Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases». Neuromolecular Medicine. 4 (1–2): 21–36. PMID 14528050. doi:10.1385/NMM:4:1-2:21
Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (2006). «Synapse Formation and Function is Modulated by the Amyloid Precursor Protein». The Journal of Neuroscience. 26 (27): 7212–21. PMID 16822978. doi:10.1523/JNEUROSCI.1450-06.2006
Turner PR, O'Connor K, Tate WP, Abraham WC (2003). «Roles of Amyloid Precursor Protein and its Fragments in Regulating Neural Activity, Plasticity and Memory». Progress in Neurobiology. 70 (1): 1–32. PMID 12927332. doi:10.1016/S0301-0082(03)00089-3
Hooper NM (2005). «Roles of Proteolysis and Lipid Rafts in the Processing of the Amyloid Precursor Protein and Prion Protein». Biochemical Society Transactions. 33 (Pt 2): 335–8. PMID 15787600. doi:10.1042/BST0330335
Ohnishi S, Takano K (2004). «Amyloid Fibrils from the Viewpoint of Protein Folding». Cellular and Molecular Life Sciences. 61 (5): 511–24. PMID 15004691. doi:10.1007/s00018-003-3264-8
Hernández F, Avila J (2007). «Tauopathies». Cellular and Molecular Life Sciences. 64 (17): 2219–33. PMID 17604998. doi:10.1007/s00018-007-7220-x
Van Broeck B, Van Broeckhoven C, Kumar-Singh S (2007). «Current Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic Approaches». Neuro-Degenerative Diseases. 4 (5): 349–65. PMID 17622778. doi:10.1159/000105156
Huang Y, Mucke L (2012). «Alzheimer Mechanisms and Therapeutic strategies». Cell. 148 (6): 1204-22. PMID 22424230. doi:10.1016/j.cell.2012.02.040
Yankner BA, Duffy LK, Kirschner DA (1990). «Neurotrophic and Neurotoxic Effects of Amyloid Beta Protein: Reversal by Tachykinin Neuropeptides». Science. 250 (4978): 279–82. PMID 2218531. doi:10.1126/science.2218531
Chen X, Yan SD (2006). «Mitochondrial Abeta: A Potential Cause of Metabolic Dysfunction in Alzheimer's Disease». IUBMB Life. 58 (12): 686–94. PMID 17424907. doi:10.1080/15216540601047767
Greig NH, Mattson MP, Perry T, Chan SL, Giordano T, Sambamurti K, Rogers JT, Ovadia H, Lahiri DK (2004). «New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF-alpha Inhibitors, and GLP-1 Receptor Agonists». Annals of the New York Academy of Sciences. 1035: 290–315. PMID 15681814. doi:10.1196/annals.1332.018
Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (2008). «New insights into brain BDNF function in normal aging and Alzheimer disease». Brain Research Reviews. 59 (1): 201–20. PMID 18708092. doi:10.1016/j.brainresrev.2008.07.007
Schindowski K, Belarbi K, Buée L (2008). «Neurotrophic factors in Alzheimer's disease: role of axonal transport». Genes, Brain, and Behavior. 7 (Suppl 1): 43–56. PMC 2228393. PMID 18184369. doi:10.1111/j.1601-183X.2007.00378.x
Mendez MF (2006). «The Accurate Diagnosis of Early-onset Dementia». International Journal of Psychiatry in Medicine. 36 (4): 401–412. PMID 17407994. doi:10.2190/Q6J4-R143-P630-KW41
Klafki HW, Staufenbiel M, Kornhuber J, Wiltfang J. Therapeutic Approaches to Alzheimer's Disease. Brain. 2006;129(Pt 11):2840–55. doi:10.1093/brain/awl280. PMID 17018549.
Schroeter ML, Stein T, Maslowski N, Neumann J (2009). «Neural Correlates of Alzheimer's Disease and Mild Cognitive Impairment: A Systematic and Quantitative Meta-Analysis involving 1,351 Patients». NeuroImage. 47 (4): 1196–1206. PMC 2730171. PMID 19463961. doi:10.1016/j.neuroimage.2009.05.037
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). «Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease». Neurology. 34 (7): 939–44. PMID 6610841. doi:10.1212/wnl.34.7.939
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007). «Research Criteria for the Diagnosis of Alzheimer's Disease: Revising the NINCDS-ADRDA Criteria». Lancet Neurology. 6 (8): 734–46. PMID 17616482. doi:10.1016/S1474-4422(07)70178-3
Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF (1994). «Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative». Archives of Neurology. 51 (12): 1198–204. PMID 7986174. doi:10.1001/archneur.1994.00540240042014
Tombaugh TN, McIntyre NJ (1992). «The mini-mental state examination: a comprehensive review». Journal of the American Geriatrics Society. 40 (9): 922–35. PMID 1512391
Pasquier F (1999). «Early diagnosis of dementia: neuropsychology». Journal of Neurology. 246 (1): 6–15. PMID 9987708. doi:10.1007/s004150050299
Harvey PD, Moriarty PJ, Kleinman L, Coyne K, Sadowsky CH, Chen M, Mirski DF (2005). «The Validation of a Caregiver Assessment of Dementia: the Dementia Severity Scale». Alzheimer Disease and Associated Disorders. 19 (4): 186–94. PMID 16327345. doi:10.1097/01.wad.0000189034.43203.60
Antoine C, Antoine P, Guermonprez P, Frigard B (2004). «Awareness of Deficits and Anosognosia in Alzheimer's Disease.». L'Encéphale (em francês). 30 (6): 570–7. PMID 15738860. doi:10.1016/S0013-7006(04)95472-3
Cruz VT, Pais J, Teixeira A, Nunes B (2004). «The Initial Symptoms of Alzheimer Disease: Caregiver Perception». Acta Médica Portuguesa. 17 (6): 435–44. PMID 16197855
Clarfield AM (2003). «The Decreasing Prevalence of Reversible Dementias: An Updated Meta-analysis». Archives of Internal Medicine. 163 (18): 2219–29. PMID 14557220. doi:10.1001/archinte.163.18.2219
Sun X, Steffens DC, Au R, Folstein M, Summergrad P, Yee J, Rosenberg I, Mwamburi DM, Qiu WQ (2008). «Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?». Archives of General Psychiatry. 65 (5): 542–550. PMC 3042807. PMID 18458206. doi:10.1001/archpsyc.65.5.542
Geldmacher DS, Whitehouse PJ (1997). «Differential Diagnosis of Alzheimer's Disease». Neurology. 48 (5 Suppl 6): S2–9. PMID 9153154
Potter GG, Steffens DC (2007). «Contribution of Depression to Cognitive Impairment and Dementia in Older adults». The Neurologist. 13 (3): 105–17. PMID 17495754. doi:10.1097/01.nrl.0000252947.15389.a9
Chong MS, Sahadevan S. Preclinical Alzheimer's disease: diagnosis and prediction of progression.. Lancet Neurology. 1 de setembro de 2005;4(9):576–9. doi:10.1016/s1474-4422(05)70168-x. PMID 16109364.
Marksteiner J, Hinterhuber H, Humpel C (2007). «Cerebrospinal Fluid Biomarkers for Diagnosis of Alzheimer's Disease: Beta-amyloid(1–42), Tau, Phospho-tau-181 and Total Protein». Drugs of Today. 43 (6): 423–31. PMID 17612711. doi:10.1358/dot.2007.43.6.1067341
De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ (2010). «Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People». Archives of Neurology. 67 (8): 949–56. PMC 2963067. PMID 20697045. doi:10.1001/archneurol.2010.179
Kawas CH (2006). «Medications and Diet: Protective Factors for AD?». Alzheimer Disease and Associated Disorders. 20 (3 Supl. 2): S89–96. PMID 16917203
Luchsinger JA, Mayeux R (2004). «Dietary Factors and Alzheimer's Disease». Lancet Neurology. 3 (10): 579–87. PMID 15380154. doi:10.1016/S1474-4422(04)00878-6
Luchsinger JA, Noble JM, Scarmeas N (2007). «Diet and Alzheimer's Disease». Current Neurology and Neuroscience Reports. 7 (5): 366–72. PMID 17764625. doi:10.1007/s11910-007-0057-8
Szekely CA, Breitner JC, Zandi PP (2007). «Prevention of Alzheimer's Disease». International Review of Psychiatry. 19 (6): 693–706. PMID 18092245. doi:10.1080/09540260701797944
Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD (2008). «Diagnosis and Treatment of Dementia: 1. Risk Assessment and Primary Prevention of Alzheimer Disease». Canadian Medical Association Journal. 178 (5): 548–56. PMC 2244657. PMID 18299540. doi:10.1503/cmaj.070796
Rosendorff C, Beeri MS, Silverman JM (2007). «Cardiovascular Risk Factors for Alzheimer's Disease». The American Journal of Geriatric Cardiology. 16 (3): 143–9. PMID 17483665. doi:10.1111/j.1076-7460.2007.06696.x
Reiss AB, Wirkowski E (2007). «Role of HMG-CoA Reductase Inhibitors in Neurological Disorders: Progress to Date». Drugs. 67 (15): 2111–20. PMID 17927279. doi:10.2165/00003495-200767150-00001
Kuller LH (2007). «Statins and Dementia». Current Atherosclerosis Reports. 9 (2): 154–61. PMID 17877925. doi:10.1007/s11883-007-0012-9
Szekely CA, Town T, Zandi PP (2007). «NSAIDs for the Chemoprevention of Alzheimer's Disease». Sub-Cellular Biochemistry. Subcellular Biochemistry. 42: 229–48. ISBN 978-1-4020-5687-1. PMID 17612054. doi:10.1007/1-4020-5688-5_11
Lehrer S. (2014). «Nasal NSAIDs for Alzheimer's Disease». Am J Alzheimers Dis Other Demen. PMID 24413537
Marjoribanks J, Farquhar C, Roberts H, Lethaby A (2012). Farquhar, Cindy, ed. «Long term hormone therapy for perimenopausal and postmenopausal women». The Cochrane Database of Systematic Reviews. 7: CD004143. PMID 22786488. doi:10.1002/14651858.CD004143.pub4
Stern Y (Julho de 2006). «Cognitive reserve and Alzheimer disease». Alzheimer Disease and Associated Disorders. 20 (2): 112–117. ISSN 0893-0341. PMID 16917199. doi:10.1097/01.wad.0000213815.20177.19
Paradise M, Cooper C, Livingston G (2009). «Systematic Review of the Effect of Education on Survival in Alzheimer's Disease». International Psychogeriatrics. 21 (1): 25–32. PMID 19026089. doi:10.1017/S1041610208008053
Sofi F, Macchi C, Abbate R, Gensini GF, Casini A (2010). «Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer's disease?». Journal of Alzheimer's Disease. 20 (3): 795–801. PMID 20182044. doi:10.3233/JAD-2010-1418
Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Santamato A, Ranieri M, Fiore P, Capurso A, Panza F (2008). «Lifestyle-related Factors in Predementia and Dementia Syndromes». Expert Review of Neurotherapeutics. 8 (1): 133–58. PMID 18088206. doi:10.1586/14737175.8.1.133
Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A (Maio de 2011). «Diet and Alzheimer's disease risk factors or prevention: the current evidence.». Expert Review of Neurotherapeutics. 11 (5): 677–708. PMID 21539488. doi:10.1586/ern.11.56
Kanoski SE, Davidson TL (18 de abril de 2011). «Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity». Physiology & Behavior. 103 (1): 59–68. PMC 3056912. PMID 21167850. doi:10.1016/j.physbeh.2010.12.003
Nehlig A (Julho de 2012). «The neuroprotective effects of cocoa flavanol and its influence on cognitive performance». British Journal of Clinical Pharmacology. 75 (3). PMID 22775434. doi:10.1111/j.1365-2125.2012.04378.x
Stoclet JC, Schini-Kerth V (Março de 2011). «Dietary flavonoids and human health». Annales Pharmaceutiques Françaises. 69 (2): 78–90. PMID 21440100. doi:10.1016/j.pharma.2010.11.004
Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Lorusso M, Santamato A, Seripa D, Pilotto A, Scafato E, Vendemiale G, Capurso A, Solfrizzi V (Maio de 2009). «Alcohol Drinking, Cognitive Functions in Older Age, Predementia, and Dementia Syndromes». Journal of Alzheimer's Disease. 17 (1): 7–31. PMID 19494429. doi:10.3233/JAD-2009-1009
Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N (2010). «Caffeine intake and dementia: systematic review and meta-analysis». Journal of Alzheimer's Disease. 20 Supl 1: S187–204. PMID 20182026. doi:10.3233/JAD-2010-091387
Ono K, Yamada M (Abril de 2012). «Vitamin A and Alzheimer's disease». Geriatrics & Gerontology International. 12 (2): 180–8. PMID 22221326. doi:10.1111/j.1447-0594.2011.00786.x
Lerner AJ, Gustaw-Rothenberg K, Smyth S, Casadesus G (Mar–Abr 2012). «Retinoids for treatment of Alzheimer's disease.». BioFactors. 38 (2): 84–9. PMID 22419567. doi:10.1002/biof.196
Heo JH, Lee KM (Março de 2013). «The possible role of antioxidant vitamin C in Alzheimer's disease treatment and prevention». American Journal of Alzheimer's Disease and Other Dementias. 28 (2): 120–5. PMID 23307795. doi:10.1177/1533317512473193
Boothby LA, Doering PL (2005). «Vitamin C and Vitamin E for Alzheimer's Disease». The Annals of Pharmacotherapy. 39 (12): 2073–80. PMID 16227450. doi:10.1345/aph.1E495
Isaac MG, Quinn R, Tabet N (2008). «Vitamin E for Alzheimer's Disease and Mild Cognitive Impairment». The Cochrane Database of Systematic Reviews (3): CD002854. PMID 18646084. doi:10.1002/14651858.CD002854.pub2
Loef M, Schrauzer GN, Walach H (2011). «Selenium and Alzheimer's disease: a systematic review». Journal of Alzheimer's Disease. 26 (1): 81–104. PMID 21593562. doi:10.3233/JAD-2011-110414
Loef M, von Stillfried N, Walach H (1 de setembro de 2012). «Zinc diet and Alzheimer's disease: a systematic review». Nutritional Neuroscience. 15 (5): 2–12. PMID 22583839. doi:10.1179/1476830512Y.0000000010
Malouf R, Grimley Evans J (2008). «Folic Acid with or without Vitamin B12 for the Prevention and Treatment of Healthy Elderly and Demented people». The Cochrane Database of Systematic Reviews (4): CD004514. PMID 18843658. doi:10.1002/14651858.CD004514.pub2
Wald DS, Kasturiratne A, Simmonds M (Junho de 2010). «Effect of Folic Acid, with or without other B vitamins, on Cognitive Decline: Meta-analysis of Randomized trials». The American Journal of Medicine. 123 (6): 522–527.e2. PMID 20569758. doi:10.1016/j.amjmed.2010.01.017
Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P (Janeiro de 2013). «Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?». Prostaglandins, Leukotrienes, and Essential Fatty Acids. 88 (1): 61–70. PMID 22575581. doi:10.1016/j.plefa.2012.04.006
Hamaguchi T, Ono K, Yamada M (Outubro de 2010). «REVIEW: Curcumin and Alzheimer's disease». CNS Neuroscience & Therapeutics. 16 (5): 285–97. PMID 20406252. doi:10.1111/j.1755-5949.2010.00147.x
Birks J, Grimley Evans J (2009). «Ginkgo Biloba for Cognitive Impairment and Dementia». The Cochrane Database of Systematic Reviews (1): CD003120. PMID 19160216. doi:10.1002/14651858.CD003120.pub3
Krishnan S, Cairns R, Howard R (2009). Krishnan, Sarada, ed. «Cannabinoids for the treatment of dementia». The Cochrane Database of Systematic Reviews (2): CD007204. PMID 19370677. doi:10.1002/14651858.CD007204.pub2
Bilkei-Gorzo A (2012). «The endocannabinoid system in normal and pathological brain ageing». Philos. Trans. R. Soc. Lond., B, Biol. Sci. 367 (1607): 3326–41. PMC 3481530. PMID 23108550. doi:10.1098/rstb.2011.0388
Pohanka M (2011). «Cholinesterases, a target of pharmacology and toxicology» (PDF). Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 155 (3): 219–229. PMID 22286807. doi:10.5507/bp.2011.036
Commission de la transparence (Junho de 2012). «Médicaments de la maladie d'Alzheimer». Prescrire International. 21 (128). 150 páginas. PMID 22822592
Birks J, Harvey RJ (25 de janeiro de 2006). Birks, Jacqueline, ed. «Donepezil for dementia due to Alzheimer's disease.». The Cochrane Database of Systematic Reviews (1): CD001190. PMID 16437430. doi:10.1002/14651858.CD001190.pub2
Geula C, Mesulam MM (1995). «Cholinesterases and the pathology of Alzheimer disease». Alzheimer Disease and Associated Disorders. 9 Suppl 2: 23–28. PMID 8534419. doi:10.1097/00002093-199501002-00005
Stahl SM (2000). «The new cholinesterase inhibitors for Alzheimer's disease, part 2: illustrating their mechanisms of action». The Journal of Clinical Psychiatry. 61 (11): 813–814. PMID 11105732. doi:10.4088/JCP.v61n1101
Birks J (2006). Birks, Jacqueline, ed. «Cholinesterase inhibitors for Alzheimer's disease». The Cochrane Database of Systematic Reviews (1): CD005593. PMID 16437532. doi:10.1002/14651858.CD005593
Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE (15 de abril de 2009). «Rivastigmine for Alzheimer's disease». The Cochrane Database of Systematic Reviews (2): CD001191. PMID 19370562. doi:10.1002/14651858.CD001191.pub2
Birks J, Harvey RJ (25 de janeiro de 2006). «Donepezil for dementia due to Alzheimer's disease». The Cochrane Database of Systematic Reviews (1): CD001190. PMID 16437430. doi:10.1002/14651858.CD001190.pub2
Raschetti R, Albanese E, Vanacore N, Maggini M (2007). «Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials». PLoS Medicine. 4 (11): e338. PMC 2082649. PMID 18044984. doi:10.1371/journal.pmed.0040338
Birks J (2006). «Cholinesterase inhibitors for Alzheimer's disease». The Cochrane Database of Systematic Reviews (1): CD005593. PMID 16437532. doi:10.1002/14651858.CD005593
Lipton SA (2006). «Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond». Nature Reviews. Drug Discovery. 5 (2): 160–170. PMID 16424917. doi:10.1038/nrd1958
Areosa Sastre A, McShane R, Sherriff F (2004). «Memantine for Dementia». The Cochrane Database of Systematic Reviews (4): CD003154. PMID 15495043. doi:10.1002/14651858.CD003154.pub2
Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M (2008). «Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline». Annals of Internal Medicine. 148 (5): 379–397. PMID 18316756. doi:10.7326/0003-4819-148-5-200803040-00009
Ballard C, Waite J (2006). Ballard, Clive G, ed. «The Effectiveness of Atypical Antipsychotics for the Treatment of Aggression and Psychosis in Alzheimer's Disease». The Cochrane Database of Systematic Reviews (1): CD003476. PMID 16437455. doi:10.1002/14651858.CD003476.pub2
Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu LM, Juszczak E (2008). Brayne, Carol, ed. «A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)». PLoS Medicine. 5 (4): e76. PMC 2276521. PMID 18384230. doi:10.1371/journal.pmed.0050076
Sink KM, Holden KF, Yaffe K (2005). «Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence». JAMA. 293 (5): 596–608. PMID 15687315. doi:10.1001/jama.293.5.596
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R (9 de janeiro de 2009). «The Dementia Antipsychotic Withdrawal Trial (DART-AD): Long-term Follow-up of a Randomised Placebo-controlled Trial». Lancet Neurology. 8 (2): 151–7. PMID 19138567. doi:10.1016/S1474-4422(08)70295-3
Rabins PV, Blacker D, Rovner BW, Rummans T, Schneider LS, Tariot PN, Blass DM, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Schneidman B, Summergrad P, Woods SM, Berger J, Cross CD, Brandt HA, Margolis PM, Shemo JP, Blinder BJ, Duncan DL, Barnovitz MA, Carino AJ, Freyberg ZZ, Gray SH, Tonnu T, Kunkle R, Albert AB, Craig TJ, Regier DA, Fochtmann LJ (Dezembro de 2007). «American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias». The American Journal of Psychiatry. 164 (12 Suppl): 5–56. PMID 18340692
Bottino CM, Carvalho IA, Alvarez AM, Avila R, Zukauskas PR, Bustamante SE, Andrade FC, Hototian SR, Saffi F, Câmargo CH (2005). «Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study». Clinical Rehabilitation. 19 (8): 861–869. PMID 16323385. doi:10.1191/0269215505cr911oa
Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL (2001). «Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology». Neurology. 56 (9): 1154–1166. PMID 11342679. doi:10.1212/WNL.56.9.1154
Hermans DG, Htay UH, McShane R (2007). Htay, U Hla, ed. «Non-pharmacological interventions for wandering of people with dementia in the domestic setting». The Cochrane Database of Systematic Reviews (1): CD005994. PMID 17253573. doi:10.1002/14651858.CD005994.pub2
Robinson L, Hutchings D, Dickinson HO, Corner L, Beyer F, Finch T, Hughes J, Vanoli A, Ballard C, Bond J (2007). «Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review». International Journal of Geriatric Psychiatry. 22 (1): 9–22. PMID 17096455. doi:10.1002/gps.1643
Woods B, Spector A, Jones C, Orrell M, Davies S (2005). Woods, Bob, ed. «Reminiscence therapy for dementia». The Cochrane Database of Systematic Reviews (2): CD001120. PMID 15846613. doi:10.1002/14651858.CD001120.pub2
Zetteler J (Novembro de 2008). «Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis». Aging & Mental Health. 12 (6): 779–85. PMID 19023729. doi:10.1080/13607860802380631
Neal M, Briggs M (2003). Neal, Martin, ed. «Validation therapy for dementia». The Cochrane Database of Systematic Reviews (3): CD001394. PMID 12917907. doi:10.1002/14651858.CD001394
Chung JC, Lai CK, Chung PM, French HP (2002). Chung, Jenny CC, ed. «Snoezelen for dementia». The Cochrane Database of Systematic Reviews (4): CD003152. PMID 12519587. doi:10.1002/14651858.CD003152
Spector A, Orrell M, Davies S, Woods B (2000). Spector, Aimee E, ed. «Withdrawn: reality orientation for dementia». The Cochrane Database of Systematic Reviews (3): CD001119. PMID 17636652. doi:10.1002/14651858.CD001119.pub2
Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, Orrell M (2003). «Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial». The British Journal of Psychiatry. 183 (3): 248–254. PMID 12948999. doi:10.1192/bjp.183.3.248
Gitlin LN, Corcoran M, Winter L, Boyce A, Hauck WW (1 de fevereiro de 2001). «A Randomized, Controlled Trial of a Home Environmental Intervention: Effect on Efficacy and Upset in Caregivers and on Daily Function of Persons with Dementia». The Gerontologist. 41 (1): 4–14. PMID 11220813. doi:10.1093/geront/41.1.4 ^{[ligação inativa]}
Gitlin LN, Hauck WW, Dennis MP, Winter L (2005). «Maintenance of Effects of the Home Environmental Skill-building Program for Family Caregivers and Individuals with Alzheimer's Disease and Related Disorders». The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 60 (3): 368–74. PMID 15860476. doi:10.1093/gerona/60.3.368
Dunne TE, Neargarder SA, Cipolloni PB, Cronin-Golomb A (2004). «Visual Contrast Enhances Food and Liquid Intake in Advanced Alzheimer's Disease». Clinical Nutrition (Edinburgh, Scotland). 23 (4): 533–538. PMID 15297089. doi:10.1016/j.clnu.2003.09.015
Dennehy C (2006). «Analysis of Patients' Rights: Dementia and PEG Insertion». British Journal of Nursing (Mark Allen Publishing). 15 (1): 18–20. PMID 16415742
Chernoff R (2006). «Tube Feeding Patients with Dementia». Nutrition in Clinical Practice. 21 (2): 142–6. PMID 16556924. doi:10.1177/0115426506021002142
Gambassi G, Landi F, Lapane KL, Sgadari A, Mor V, Bernabei R (1999). «Predictors of Mortality in Patients with Alzheimer's Disease Living in Nursing Homes». Journal of Neurology, Neurosurgery, and Psychiatry. 67 (1): 59–65. PMC 1736445. PMID 10369823. doi:10.1136/jnnp.67.1.59
Problemas de saúde:
- Head B (2003). «Palliative Care for Persons with Dementia». Home Healthcare Nurse. 21 (1): 53–61. PMID 12544465. doi:10.1097/00004045-200301000-00012
- Shega JW, Levin A, Hougham GW, Cox-Hayley D, Luchins D, Hanrahan P, Stocking C, Sachs GA (2003). «Palliative Excellence in Alzheimer Care Efforts (PEACE): A Program Description». Journal of Palliative Medicine. 6 (2): 315–20. PMID 12854952. doi:10.1089/109662103764978641
- Mölsä PK, Marttila RJ, Rinne UK (1986). «Survival and Cause of Death in Alzheimer's Disease and Multi-Infarct Dementia». Acta Neurologica Scandinavica. 74 (2): 103–7. PMID 3776457. doi:10.1111/j.1600-0404.1986.tb04634.x
- Bowen JD, Malter AD, Sheppard L, Kukull WA, McCormick WC, Teri L, Larson EB (1996). «Predictors of Mortality in Patients Diagnosed with Probable Alzheimer's Disease». Neurology. 47 (2): 433–9. PMID 8757016
- Dodge HH, Shen C, Pandav R, DeKosky ST, Ganguli M (2003). «Functional Transitions and Active Life Expectancy Associated with Alzheimer Disease». Archives of Neurology. 60 (2): 253–9. PMID 12580712. doi:10.1001/archneur.60.2.253
- Mölsä PK, Marttila RJ, Rinne UK (1995). «Long-Term Survival and Predictors of Mortality in Alzheimer's Disease and Multi-Infarct Dementia». Acta Neurologica Scandinavica. 91 (3): 159–64. PMID 7793228
- Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST (2005). «Alzheimer Disease and Mortality: A 15-year Epidemiological Study». Archives of Neurology. 62 (5): 779–84. PMID 15883266. doi:10.1001/archneur.62.5.779
- Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA (2004). «Survival after Initial Diagnosis of Alzheimer Disease». Annals of Internal Medicine. 140 (7): 501–9. PMID 15068977
- Jagger C, Clarke M, Stone A (1995). «Predictors of Survival with Alzheimer's Disease: A Community-based Study». Psychological Medicine. 25 (1): 171–7. PMID 7792352. doi:10.1017/S0033291700028191
- Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Román GC (2008). «Incidence and subtypes of dementia in three elderly populations of central Spain». Journal of the Neurological Sciences. 264 (1–2): 63–72. PMID 17727890. doi:10.1016/j.jns.2007.07.021
- Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G, Inzitari D (2002). «Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study». Journal of the American Geriatrics Society. 50 (1): 41–8. PMID 12028245. doi:10.1046/j.1532-5415.2002.50006.x
- Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (1999). «Gender Differences in the Incidence of AD and Vascular Dementia: The EURODEM Studies. EURODEM Incidence Research Group». Neurology. 53 (9): 1992–7. PMID 10599770
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003). «Alzheimer Disease in the US population: Prevalence Estimates Using the 2000 census». Archives of Neurology. 60 (8): 1119–22. PMID 12925369. doi:10.1001/archneur.60.8.1119
- Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005). «Global Prevalence of Dementia: A Delphi Consensus Study». Lancet. 366 (9503): 2112–7. PMC 2850264. PMID 16360788. doi:10.1016/S0140-6736(05)67889-0
- Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007). «Forecasting the global burden of Alzheimer's disease». Alzheimer's & Dementia. 3 (3): 186–91. PMID 19595937. doi:10.1016/j.jalz.2007.04.381
- Berchtold NC, Cotman CW (1998). «Evolution in the Conceptualization of Dementia and Alzheimer's Disease: Greco-Roman Period to the 1960s». Neurobiology of Aging. 19 (3): 173–89. PMID 9661992. doi:10.1016/S0197-4580(98)00052-9
- Alzheimer Alois; L. Jarvik and H. Greenson (1987). «About a Peculiar Disease of the Cerebral Cortex». Alzheimer Disease and Associated Disorders. 1 (1): 3–8. PMID 3331112
- Boller F, Forbes MM (1998). «History of Dementia and Dementia in History: An Overview». Journal of the Neurological Sciences. 158 (2): 125–33. PMID 9702682. doi:10.1016/S0022-510X(98)00128-2
- Amaducci LA, Rocca WA, Schoenberg BS. Origin of the Distinction between Alzheimer's Disease and Senile Dementia: How History Can Clarify Nosology. Neurology. 1986;36(11):1497–9. PMID 3531918.
- Allegri RF, Butman J, Arizaga RL, Machnicki G, Serrano C, Taragano FE, Sarasola D, Lon L (2007). «Economic Impact of Dementia in Developing Countries: An Evaluation of Costs of Alzheimer-type Dementia in Argentina». International Psychogeriatrics. 19 (4): 705–18. PMID 16870037. doi:10.1017/S1041610206003784
- Suh GH, Knapp M, Kang CJ (2006). «The Economic Costs of Dementia in Korea, 2002». International Journal of Geriatric Psychiatry. 21 (8): 722–8. PMID 16858741. doi:10.1002/gps.1552
- Wimo A, Jonsson L, Winblad B (2006). «An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003». Dementia and Geriatric Cognitive Disorders. 21 (3): 175–81. PMID 16401889. doi:10.1159/000090733
- Moore MJ, Zhu CW, Clipp EC (2001). «Informal Costs of Dementia Care: Estimates from the National Longitudinal Caregiver Study». The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 56 (4): S219–28. PMID 11445614. doi:10.1093/geronb/56.4.S219
- Jönsson L, Eriksdotter Jönhagen M, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A (2006). «Determinants of Costs of Care for Patients with Alzheimer's Disease». International Journal of Geriatric Psychiatry. 21 (5): 449–59. PMID 16676288. doi:10.1002/gps.1489
- Schneider J, Murray J, Banerjee S, Mann A (1999). «EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I—Factors associated with carer burden». International Journal of Geriatric Psychiatry. 14 (8): 651–661. PMID 10489656. doi:10.1002/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B
- Murray J, Schneider J, Banerjee S, Mann A (1999). «EUROCARE: A Cross-National Study of Co-resident Spouse Carers for People with Alzheimer's Disease: II—A Qualitative Analysis of the Experience of Caregiving». International Journal of Geriatric Psychiatry. 14 (8): 662–7. PMID 10489657. doi:10.1002/(SICI)1099-1166(199908)14:8<662::AID-GPS993>3.0.CO;2-4
- Zhu CW, Sano M (2006). «Economic Considerations in the Management of Alzheimer's Disease». Clinical Interventions in Aging. 1 (2): 143–54. PMC 2695165. PMID 18044111. doi:10.2147/ciia.2006.1.2.143
- Gaugler JE, Kane RL, Kane RA, Newcomer R (2005). «Early Community-based Service Utilization and Its Effects on Institutionalization in Dementia Caregiving». The Gerontologist. 45 (2): 177–85. PMID 15799982. doi:10.1093/geront/45.2.177
- Ritchie K, Lovestone S (2002). «The Dementias». Lancet. 360 (9347): 1759–66. PMID 12480441. doi:10.1016/S0140-6736(02)11667-9
- Brodaty H, Hadzi-Pavlovic D (1990). «Psychosocial Effects on Carers of Living with Persons with Dementia». The Australian and New Zealand Journal of Psychiatry. 24 (3): 351–61. PMID 2241719. doi:10.3109/00048679009077702
- Donaldson C, Tarrier N, Burns A (1998). «Determinants of Carer Stress in Alzheimer's Disease». International Journal of Geriatric Psychiatry. 13 (4): 248–56. PMID 9646153. doi:10.1002/(SICI)1099-1166(199804)13:4<248::AID-GPS770>3.0.CO;2-0
- Pusey H, Richards D (2001). «A Systematic Review of the Effectiveness of Psychosocial Interventions for Carers of People with Dementia». Aging & Mental Health. 5 (2): 107–19. PMID 11511058. doi:10.1080/13607860120038302
- Lashuel HA, Hartley DM, Balakhaneh D, Aggarwal A, Teichberg S, Callaway DJ (2002). «New Class of Inhibitors of Beta-amyloid Fibril Formation. Implications for the Mechanism of Pathogenesis in Alzheimer's Disease». The Journal of Biological Chemistry. 277 (45): 42881–42890. PMID 12167652. doi:10.1074/jbc.M206593200
- Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W (2010). «Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence». Drugs. 70 (5): 513–528. PMID 20329802. doi:10.2165/11533070-000000000-00000. Consultado em 22 de novembro de 2014. Arquivado do original em 17 de setembro de 2011
- Vacinação:
  - Hawkes CA, McLaurin J (2007). «Immunotherapy as Treatment for Alzheimer's Disease». Expert Review of Neurotherapeutics. 7 (11): 1535–48. PMID 17997702. doi:10.1586/14737175.7.11.1535
  - Investigação relativa ao etanercepte:
    - Tobinick E (setembro de 2009). «Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence». CNS Drugs. 23 (9): 713-25. PMID 19689163. doi:10.2165/11310810-000000000-00000
    - Martin C, Solís L, Concha MI, Otth C (Junho de 2011). «Herpes simplex virus tipo 1 como factor de riesgo asociado con la enfermedad de Alzheimer». Revista Médica De Chile. 139 (6): 779–86. PMID 22051760. doi:10.4067/S0034-98872011000600013
    - Wozniak MA, Mee AP, Itzhaki RF (2008). «Herpes Simplex Virus type 1 DNA Is Located within Alzheimer's Disease Amyloid Plaques». The Journal of Pathology. 217 (1): 131–138. PMID 18973185. doi:10.1002/path.2449
    - Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D (2008). «Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study». Lancet. 372 (9634): 207–15. PMID 18640457. doi:10.1016/S0140-6736(08)61074-0
    - Bezprozvanny I (Outubro de 2010). «The rise and fall of Dimebon». Drug News & Perspectives. 23 (8): 518–23. PMID 21031168. doi:10.1358/dnp.2010.23.8.1500435
    - Wendler A, Wehling M (2012). «Translatability scoring in drug development: eight case studies». Journal of Translational Medicine. 10 (10): 39. PMID 22397594. doi:10.1186/1479-5876-10-39
    - Baddeley TC, McCaffrey J, Storey JM, Cheung JK, Melis V, Horsley D, Harrington CR, Wischik CM (15 de outubro de 2014). «Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease». J Pharmacol Exp Ther. PMID 25320049. doi:10.1124/jpet.114.219352
    - Wischik CM, Harrington CR, Storey JM (15 de abril de 2014). «Tau-aggregation inhibitor therapy for Alzheimer's disease». Biochem Pharmacol. 88 (4): 529-39. PMID 24361915. doi:10.1016/j.bcp.2013.12.008
    - Szekely CA, Thorne JE, Zandi PP; et al. (2004). «Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.». Neuroepidemiology. 23 (4): 159-169. PMID 15279021
    - Tuppo EE, Arias HR. (2005). «The role of inflammation in Alzheimer's disease.». Int J Biochem Cell Biol. 37 (2): 289-305
    - Mechanisms of gamma oscillations por Buzsáki G, Wang XJ, PMID 22443509 PMCID: PMC4049541 DOI: 10.1146/annurev-neuro-062111-150444 (2012)
    - Dougall NJ, Bruggink S, Ebmeier KP (2004). «Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia». The American Journal of Geriatric Psychiatry. 12 (6): 554–70. PMID 15545324. doi:10.1176/appi.ajgp.12.6.554
    - O'Brien JT (Dezembro de 2007). «Role of Imaging Techniques in the Diagnosis of Dementia». The British Journal of Radiology. 80 (Spec No 2): S71–7. PMID 18445747. doi:10.1259/bjr/33117326
    - Carpenter AP, Pontecorvo MJ, Hefti FF, Skovronsky DM (Agosto de 2009). «The Use of the Exploratory IND in the Evaluation and Development of¹⁸F-PET Radiopharmaceuticals for Amyloid Imaging in the Brain: A Review of One Company's Experience». The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 53 (4): 387–93. PMID 19834448
    nia.nih.gov
    - «About Alzheimer's Disease: Symptoms». National Institute on Aging. Consultado em 28 de dezembro de 2011. Cópia arquivada em 15 de janeiro de 2012
    - «So, What Can You Do?» (em inglês). National Institute on Aging. 29 de julho de 2016. Arquivado do original em 3 de abril de 2017
    nih.gov
    - «Independent Panel Finds Insufficient Evidence to Support Preventive Measures for Alzheimer's Disease». National Institutes of Health. 28 de abril de 2010
    consensus.nih.gov
    - Daviglus ML; et al. (26–28 de abril de 2010). «NIH State-of-the-Science Conference: Preventing Alzheimer's Disease and Cognitive Decline»

nytimes.com

Pam Belluck, Rebecca Robbins (7 de junho de 2021). «F.D.A. Approves Alzheimer's Drug Despite Fierce Debate Over Whether It Works». The New York Times. Consultado em 7 de junho de 2021

obviousmag.org

lounge.obviousmag.org

AQUELA MÚSICA QUE NÃO SAI DA SUA CABEÇA por Fabiola Donadao (2014)

patientslikeme.com

patientslikeme

physorg.com

Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R (9 de janeiro de 2009). «The Dementia Antipsychotic Withdrawal Trial (DART-AD): Long-term Follow-up of a Randomised Placebo-controlled Trial». Lancet Neurology. 8 (2): 151–7. PMID 19138567. doi:10.1016/S1474-4422(08)70295-3

scielo.br

Ricardo Nitrini; Paulo Caramelli; Cássio Machado de Campos Bottino; Benito Pereira Damasceno; Sonia Maria Dozzi Brucki; Renato Anghinah (2005). «Diagnóstico de doença de Alzheimer no Brasil: critérios diagnósticos e exames complementares.». Recomendações do Departamento Científico de Neurologia Cognitiva e do Envelhecimento da Academia Brasileira de Neurologia. Arq. Neuro-Psiquiatr. 63 (3a). doi:10.1590/S0004-282X2005000400033

techexplorist.com

«An algorithm to predict Alzheimer's». Tech Explorist (em inglês). 18 de dezembro de 2019. Consultado em 18 de dezembro de 2019

technology.org

«Alzheimer's breakthrough: brain metals that may drive disease progression revealed». Technology Org (em inglês). 21 de junho de 2018

ucl.ac.uk

pnas.org.libproxy.ucl.ac.uk

Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D, Jardanhazi-Kurutz D, Walter J, Kirchhoff F, Hanisch UK, Kummer MP. (2010). «Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine» (PDF). Proceedings of the National Academy of Sciences of the United States of America. 107: 6058–6063. PMID 20231476. doi:10.1073/pnas.0909586107

discovery.ucl.ac.uk

Wischik Claude M, Bentham Peter, Wischik Damon J, Seng Kwang Meng (2008). «Tau aggregation inhibitor (TAI) therapy with remberTM arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks». Alzheimer's Association. Alzheimer's & Dementia. 4 (4): T167. doi:10.1016/j.jalz.2008.05.438

ufrj.br

eean.ufrj.br

Poliana de França Albuquerque Paes, Fátima Helena do Espírito Santo (2005). «Limites e Possibilidades no Cotidiano do Familiar que Cuida do Idoso com Alzheimer no Ambiente Domiciliar» (PDF). Universidade Federal do Rio de Janeiro. Escola Anna Nery Revista de Enfermagem. 9 (2): 192-198. Consultado em 3 de março de 2011. Arquivado do original (PDF) em 22 de dezembro de 2009

un.org

«World population prospects: the 2006 revision, highlights» (PDF). Population Division, Department of Economic and Social Affairs, United Nations. 2007. Consultado em 10 de outubro de 2014. Arquivado do original (PDF) em 19 de agosto de 2008

upol.cz

biomed.papers.upol.cz

Pohanka M (2011). «Cholinesterases, a target of pharmacology and toxicology» (PDF). Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 155 (3): 219–229. PMID 22286807. doi:10.5507/bp.2011.036

web.archive.org

«Dementia Fact sheet N°362». World Health Organization. Março de 2015. Consultado em 13 de janeiro de 2016. Cópia arquivada em 18 de março de 2015
«Dementia diagnosis and assessment» (PDF). National Institute for Health and Care Excellence (NICE). Consultado em 30 de novembro de 2014. Cópia arquivada (PDF) em 5 de dezembro de 2014
«About Alzheimer's Disease: Symptoms». National Institute on Aging. Consultado em 28 de dezembro de 2011. Cópia arquivada em 15 de janeiro de 2012
«So, What Can You Do?» (em inglês). National Institute on Aging. 29 de julho de 2016. Arquivado do original em 3 de abril de 2017
National Institute for Health and Clinical Excellence. «Low-dose antipsychotics in people with dementia». National Institute for Health and Care Excellence (NICE). Consultado em 29 de novembro de 2014. Arquivado do original em 5 de dezembro de 2014
«Information for Healthcare Professionals: Conventional Antipsychotics». US Food and Drug Administration. 16 de junho de 2008. Consultado em 29 de novembro de 2014. Cópia arquivada em 29 de novembro de 2014
Dementia: Quick Reference Guide (PDF). London: National Institute for Health and Clinical Excellence. Novembro de 2006. ISBN 1-84629-312-X. Consultado em 9 de outubro de 2014. Arquivado do original (PDF) em 27 de fevereiro de 2008
«Namenda prescribing information» (PDF). Forest Pharmaceuticals. Consultado em 19 de fevereiro de 2008. Arquivado do original (PDF) em 27 de fevereiro de 2008
«Anxiety and Agitation». Alzheimer's Association. 2006. Consultado em 25 de setembro de 2006. Cópia arquivada em 25 de setembro de 2006
«Profiles of General Demographic Characteristics, 2000 Census of Population and Housing, United States» (PDF). U.S. Census Bureau. 2001. Consultado em 10 de outubro de 2014. Cópia arquivada (PDF) em 19 de agosto de 2008
«World population prospects: the 2006 revision, highlights» (PDF). Population Division, Department of Economic and Social Affairs, United Nations. 2007. Consultado em 10 de outubro de 2014. Arquivado do original (PDF) em 19 de agosto de 2008
«The MetLife study of Alzheimer's disease: The caregiving experience» (PDF). MetLife Mature Market Institute. Agosto de 2006. Consultado em 5 de Fevereiro de 2011. Arquivado do original (PDF) em 8 de janeiro de 2011
Poliana de França Albuquerque Paes, Fátima Helena do Espírito Santo (2005). «Limites e Possibilidades no Cotidiano do Familiar que Cuida do Idoso com Alzheimer no Ambiente Domiciliar» (PDF). Universidade Federal do Rio de Janeiro. Escola Anna Nery Revista de Enfermagem. 9 (2): 192-198. Consultado em 3 de março de 2011. Arquivado do original (PDF) em 22 de dezembro de 2009
Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W (2010). «Intravenous Immunoglobulins as a Treatment for Alzheimer's Disease: Rationale and Current Evidence». Drugs. 70 (5): 513–528. PMID 20329802. doi:10.2165/11533070-000000000-00000. Consultado em 22 de novembro de 2014. Arquivado do original em 17 de setembro de 2011
«Bapineuzumab in Patients with Mild to Moderate Alzheimer's Disease/ Apo_e4 Non-carriers». US National Institutes of Health. 29 de fevereiro de 2008. Consultado em 23 de março de 2008. Cópia arquivada em 22 de março de 2008
«Pfizer And Medivation announce results from two phase 3 studies in Dimebon (latrepirdine*) Alzheimer's disease clinical development program (NASDAQ:MDVN)». Consultado em 16 de novembro de 2012. Arquivado do original em 4 de setembro de 2012
«Cópia arquivada». Consultado em 24 de julho de 2015. Arquivado do original em 26 de julho de 2015

wellcome.ac.uk

#Hooked: a citizen science experiment into what makes music memorable Researchers hope a newly launched experiment on music hooks could help future research into Alzheimer’s disease. pelo "Wellcome" (2013)

who.int

«Dementia Fact sheet N°362». World Health Organization. Março de 2015. Consultado em 13 de janeiro de 2016. Cópia arquivada em 18 de março de 2015
World Health Organization (2006). Neurological Disorders: Public Health Challenges. Switzerland: World Health Organization. pp. 204–207. ISBN 978-92-4-156336-9

wiley.com

onlinelibrary.wiley.com

Sampson EL, Candy B, Jones L (2009). «Enteral tube feeding for older people with advanced dementia (Intervention Review)». The Cochrane Library (2). doi:10.1002/14651858.CD007209.pub2

worldcat.org

Burns A, Iliffe S (fevereiro de 2009). «Alzheimer's disease». BMJ. 338: b158. ISSN 0959-8138. PMID 19196745. doi:10.1136/bmj.b158. (pede subscrição (ajuda))
Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M (19 de fevereiro de 2009). «APP Binds DR6 to Cause Axon Pruning and Neuron Death via Distinct Caspases». Nature. 457 (7232): 981–989. ISSN 0028-0836. PMC 2677572. PMID 19225519. doi:10.1038/nature07767
Itzhaki RF, Wozniak MA (2008). «Herpes Simplex Virus Type 1 in Alzheimer's Disease: The Enemy Within». Journal of Alzheimer's Disease. 13 (4): 393–405. ISSN 1387-2877. PMID 18487848
Stern Y (Julho de 2006). «Cognitive reserve and Alzheimer disease». Alzheimer Disease and Associated Disorders. 20 (2): 112–117. ISSN 0893-0341. PMID 16917199. doi:10.1097/01.wad.0000213815.20177.19

Doença de Alzheimer (Portuguese Wikipedia)

abril.com.br

info.abril.com.br

adisonline.com

alz.org

ama-assn.org

archpsyc.ama-assn.org

arquivo.pt

bepress.com

works.bepress.com

books.google.com

brightfocus.org

bvsalud.org

pepsic.bvsalud.org

census.gov

clinicaltrials.gov

cnn.com

consumerreports.org

curetogether.com

dgs.pt

diagnosticimaging.com

discovermagazine.com

blogs.discovermagazine.com

doi.org

dx.doi.org

europa.eu

ec.europa.eu

fda.gov

frx.com

gerontologyjournals.org

gerontologist.gerontologyjournals.org

jbc.org

kurzweilai.net

medcitynews.com

medivation.com

investors.medivation.com

metapress.com

iospress.metapress.com

metlife.com

mit.edu

news.mit.edu

neurology.org

nice.org.uk

nice.org.uk

pathways.nice.org.uk

nih.gov

ncbi.nlm.nih.gov

nia.nih.gov

nih.gov

consensus.nih.gov

nytimes.com

obviousmag.org

lounge.obviousmag.org

patientslikeme.com

physorg.com

scielo.br

techexplorist.com

technology.org

ucl.ac.uk

pnas.org.libproxy.ucl.ac.uk

discovery.ucl.ac.uk

ufrj.br

eean.ufrj.br

un.org

upol.cz

biomed.papers.upol.cz

web.archive.org

wellcome.ac.uk

who.int

wiley.com

onlinelibrary.wiley.com

worldcat.org